{
    "studies": [
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT03361540",
                    "orgStudyIdInfo": {
                        "id": "8302-CL-0101"
                    },
                    "organization": {
                        "fullName": "Astellas Pharma Inc",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "ASP8302 Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Subjects",
                    "officialTitle": "A Placebo-controlled, Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Male and Female Subjects"
                },
                "statusModule": {
                    "statusVerifiedDate": "2019-04",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2017-11-14",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2018-04-30",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2018-04-30",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2017-11-14",
                    "studyFirstSubmitQcDate": "2017-11-28",
                    "studyFirstPostDateStruct": {
                        "date": "2017-12-05",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-18",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Astellas Pharma Inc",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "The objective of this study is to evaluate the safety, tolerability and pharmacokinetic of single/multiple ascending oral doses of ASP8302 in non-elderly healthy Japanese male and female subjects."
                },
                "conditionsModule": {
                    "conditions": [
                        "Healthy Subjects"
                    ],
                    "keywords": [
                        "Pharmacokinetics",
                        "Safety",
                        "ASP8302"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE1"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "SEQUENTIAL",
                        "primaryPurpose": "BASIC_SCIENCE",
                        "maskingInfo": {
                            "masking": "TRIPLE",
                            "whoMasked": [
                                "PARTICIPANT",
                                "CARE_PROVIDER",
                                "INVESTIGATOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 56,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Single dose of ASP8302 dose-1",
                            "type": "EXPERIMENTAL",
                            "description": "Subjects will receive a single dose of ASP8302.",
                            "interventionNames": [
                                "Drug: ASP8302"
                            ]
                        },
                        {
                            "label": "Single dose of ASP8302 dose-2",
                            "type": "EXPERIMENTAL",
                            "description": "Subjects will receive a single dose of ASP8302.",
                            "interventionNames": [
                                "Drug: ASP8302"
                            ]
                        },
                        {
                            "label": "Single dose of ASP8302 dose-3",
                            "type": "EXPERIMENTAL",
                            "description": "Subjects will receive a single dose of ASP8302.",
                            "interventionNames": [
                                "Drug: ASP8302"
                            ]
                        },
                        {
                            "label": "Single dose of ASP8302 dose-4",
                            "type": "EXPERIMENTAL",
                            "description": "Subjects will receive a single dose of ASP8302.",
                            "interventionNames": [
                                "Drug: ASP8302"
                            ]
                        },
                        {
                            "label": "Single dose of Placebo",
                            "type": "PLACEBO_COMPARATOR",
                            "description": "Subjects will receive a single dose of Placebo.",
                            "interventionNames": [
                                "Drug: Placebo"
                            ]
                        },
                        {
                            "label": "Multiple dose of ASP8302 dose-5",
                            "type": "EXPERIMENTAL",
                            "description": "Subjects will receive once daily dosing of ASP8302 for 14 consecutive days at the same dose level.",
                            "interventionNames": [
                                "Drug: ASP8302"
                            ]
                        },
                        {
                            "label": "Multiple dose of ASP8302 dose-6",
                            "type": "EXPERIMENTAL",
                            "description": "Subjects will receive once daily dosing of ASP8302 for 14 consecutive days at the same dose level.",
                            "interventionNames": [
                                "Drug: ASP8302"
                            ]
                        },
                        {
                            "label": "Multiple dose of Placebo",
                            "type": "PLACEBO_COMPARATOR",
                            "description": "Subjects will receive once daily dosing of Placebo for 14 consecutive days.",
                            "interventionNames": [
                                "Drug: Placebo"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "ASP8302",
                            "description": "ASP8302 will be administered orally.",
                            "armGroupLabels": [
                                "Multiple dose of ASP8302 dose-5",
                                "Multiple dose of ASP8302 dose-6",
                                "Single dose of ASP8302 dose-1",
                                "Single dose of ASP8302 dose-2",
                                "Single dose of ASP8302 dose-3",
                                "Single dose of ASP8302 dose-4"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Placebo",
                            "description": "Placebo will be administered orally.",
                            "armGroupLabels": [
                                "Multiple dose of Placebo",
                                "Single dose of Placebo"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Safety assessed by incidence of adverse events (AEs)",
                            "description": "Adverse events will be coded using Medical Dictionary for Regulatory Activities (MedDRA).",
                            "timeFrame": "Up to Day 6 in single ascending dose (SAD) part Up to Day 19 in MAD part"
                        },
                        {
                            "measure": "Safety assessed by vital signs: Body temperature",
                            "description": "To assess vital signs as a criteria of safety variables.",
                            "timeFrame": "Up to Day 6 in SAD part Up to Day 19 in multiple ascending dose (MAD) part"
                        },
                        {
                            "measure": "Safety assessed by vital signs: Blood pressure",
                            "description": "To assess vital signs as a criteria of safety variables.",
                            "timeFrame": "Up to Day 6 in SAD part Up to Day 19 in MAD part"
                        },
                        {
                            "measure": "Safety assessed by vital signs: Pulse rate",
                            "description": "To assess vital signs as a criteria of safety variables.",
                            "timeFrame": "Up to Day 6 in SAD part Up to Day 19 in MAD part"
                        },
                        {
                            "measure": "Number of participants with laboratory value abnormalities and/or AEs",
                            "description": "Number of participants with potentially clinically significant laboratory values.",
                            "timeFrame": "Up to Day 6 in SAD part Up to Day 19 in MAD part"
                        },
                        {
                            "measure": "Safety assessed by cardiac troponin",
                            "description": "To assess the cardiovascular system function as a criteria of safety variables.",
                            "timeFrame": "Up to Day 6 in SAD part Up to Day 19 in MAD part"
                        },
                        {
                            "measure": "Safety assessed by standard 12-lead electrocardiogram",
                            "description": "To assess the cardiovascular system function as a criteria of safety variables.",
                            "timeFrame": "Up to Day 6 in SAD part Up to Day 19 in MAD part"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Pharmacokinetics (PK) parameter for ASP8302: Maximum observed concentration (Cmax) in plasma",
                            "description": "To assess the PK of ASP8302 in SAD part and MAD part.",
                            "timeFrame": "Up to 72 hr after dosing in SAD part Day 1 and Day 14 in MAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: Time of the Maximum Concentration (tmax) in plasma",
                            "description": "To assess the PK of ASP8302 in SAD part and MAD part.",
                            "timeFrame": "Up to 72 hr after dosing in SAD part Day 1 and Day 14 in MAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: Area under the concentration-time curve (AUC) from the time of dosing to 24h after dosing (AUC24) in plasma",
                            "description": "To assess the PK of ASP8302 in SAD part and MAD part.",
                            "timeFrame": "Up to 72 hr after dosing in SAD part Day 1 in MAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: AUC from the Time of Dosing Extrapolated to Time Infinity (AUCinf) in plasma",
                            "description": "To assess the PK of ASP8302 in SAD part.",
                            "timeFrame": "Up to 72 hr after dosing in SAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: AUC from the Time of Dosing to the Start of the Next Dosing Interval (AUCtau) in plasma",
                            "description": "To assess the PK of ASP8302 in MAD part.",
                            "timeFrame": "Day 14 in MAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: Peak-Trough Ratio (PTR) in plasma",
                            "description": "To assess the PK of ASP8302 in MAD part.",
                            "timeFrame": "Day 14 in MAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: Accumulation Ratio for AUC (Rac(AUC)) in plasma",
                            "description": "To assess the PK of ASP8302 in MAD part.",
                            "timeFrame": "Day 14 in MAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: Accumulation Ratio for Cmax (Rac(Cmax)) in plasma",
                            "description": "To assess the PK of ASP8302 in MAD part.",
                            "timeFrame": "Day 14 in MAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: AUC from the Time of Dosing to the Last Measurable Concentration (AUClast) in plasma",
                            "description": "To assess the PK of ASP8302 in SAD part.",
                            "timeFrame": "Up to 72 hr after dosing in SAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: Time Point Prior to the Time Point Corresponding to the First Measurable (Non-zero) Concentration (tlag) in plasma",
                            "description": "To assess the PK of ASP8302 in SAD part and MAD part.",
                            "timeFrame": "Up to 72 hr after dosing in SAD part Day 1 in MAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: Terminal Elimination Half-life (t1/2) in plasma",
                            "description": "To assess the PK of ASP8302 in SAD part and MAD part.",
                            "timeFrame": "Up to 72 hr after dosing in SAD part Day 14 in MAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: Apparent Volume of Distribution during the Terminal Elimination Phase After Single Extra-Vascular Dosing (Vz/F) in plasma",
                            "description": "To assess the PK of ASP8302 in SAD part.",
                            "timeFrame": "Up to 72 hr after dosing in SAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: Apparent Total Systemic Clearance After Single or Multiple Extra-Vascular Dosing (CL/F) in plasma",
                            "description": "To assess the PK of ASP8302 in SAD part and MAD part.",
                            "timeFrame": "Up to 72 hr after dosing in SAD part Day 14 in MAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: Concentration Immediately Prior to Dosing at Multiple Dosing (Ctrough) in plasma",
                            "description": "To assess the PK of ASP8302 in MAD part.",
                            "timeFrame": "Up to Day 14 in MAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: Amount excreted into urine from the time of dosing to the 72 hours after dosing (Ae72) in urine",
                            "description": "To assess the PK of ASP8302 in SAD part.",
                            "timeFrame": "Up to 72 hr after dosing in SAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: Fraction excreted into urine from the time of dosing to the 72 hours after dosing (Ae72%) in urine",
                            "description": "To assess the PK of ASP8302 in SAD part.",
                            "timeFrame": "Up to 72 hr after dosing in SAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: Renal clearance (CLR) in urine",
                            "description": "To assess the PK of ASP8302 in SAD part and MAD part.",
                            "timeFrame": "Up to 72 hr after dosing in SAD part Day 14 in MAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: Amount excreted into urine over the time interval between consecutive dosing (Aetau) in urine",
                            "description": "To assess the PK of ASP8302 in MAD part.",
                            "timeFrame": "Day 14 in MAD part"
                        },
                        {
                            "measure": "PK parameter for ASP8302: Fraction excreted into urine over the time interval between consecutive dosing (Aetau%) in urine",
                            "description": "To assess the PK of ASP8302 in MAD part.",
                            "timeFrame": "Day 14 in MAD part"
                        },
                        {
                            "measure": "Pharmacodynamic (PD) parameter for ASP8302: Pupil diameter",
                            "description": "To assess the PD of ASP8302 in SAD part and MAD part.",
                            "timeFrame": "Up to 24 hr after dosing in SAD part Up to Day 14 in MAD part"
                        },
                        {
                            "measure": "PD parameter for ASP8302: Salivary secretion",
                            "description": "To assess the PD of ASP8302 in SAD part and MAD part.",
                            "timeFrame": "Up to 24 hr after dosing in SAD part Up to Day 14 in MAD part"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Body weight at screening: \u2265 50.0 kg and \\< 80.0 kg for male, \u2265 40.0 kg and \\< 70.0 kg for female.\n* Body-mass index (BMI) at screening: \u2265 17.6 kg/m2 and \\< 26.4 kg/m2 \\[BMI = Body weight (kg) \u00f7 {Body height (m)2}\\].\n\nExclusion Criteria:\n\n* Subjects who participated or are scheduled to participate in any clinical trials or post-marketing studies within 120 days before screening test or during the screening test to the hospital admission (Day -2).\n* Subjects who conducted or is scheduled to conduct any of the blood donation or blood drawing in designated period before Day -2\n* Subject who received or is scheduled to receive any medications within seven days before the hospital admission.\n* Any deviation from any of the normal range of blood pressure, pulse rate, body temperature and standard 12-lead electrocardiogram at screening or on the day of hospital admission (Day -1).\n* Subject who meets any of the criteria for laboratory tests at screening or on the day of hospital admission (Day -2).\n* Any deviation from the normal range of routine 12-lead electrocardiogram at screening.\n* Subjects with a complication or history of drug allergies.\n* Subjects who developed upper gastrointestinal symptoms within seven days before the hospital admission.\n* Subjects with a complication or history of hepatic disease.\n* Subjects with a complication or history of cardiac disease.\n* Subjects with a complication or history of respiratory disease except for history of asthma in childhood.\n* Subjects with a complication or history of gastrointestinal disease except for a history of appendicitis.\n* Subjects with a history of gastrointestinal resection except for appendicitis.\n* Subjects with a complication or history of renal disease except for a history of calculus.\n* Subjects with a complication or history of endocrine disease.\n* Subjects with a complication or history of cerebrovascular disease.\n* Subjects with a complication or history of malignant tumor.\n* Subjects who received ASP8302 previously.\n* Subjects who have a habit of excessive smoking or drinking alcohol.",
                    "healthyVolunteers": true,
                    "sex": "ALL",
                    "minimumAge": "20 Years",
                    "maximumAge": "44 Years",
                    "stdAges": [
                        "ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Medical Director",
                            "affiliation": "Astellas Pharma Inc",
                            "role": "STUDY_DIRECTOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Site JP00001",
                            "city": "Toshima",
                            "state": "Tokyo",
                            "country": "Japan"
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO",
                    "description": "Access to anonymized individual participant level data will not be provided for this trial. Further details on Astellas' data sharing policy can be found at https://www.clinicaltrials.astellas.com/transparency/."
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT05378269",
                    "orgStudyIdInfo": {
                        "id": "DARE-VVA-001"
                    },
                    "organization": {
                        "fullName": "Dar\u00e9 Bioscience, Inc.",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA",
                    "officialTitle": "Phase 1/2 Study of Intravaginal Tamoxifen (DARE-VVA1): Randomized, Double-blind, Placebo-controlled Study of Safety, Pharmacokinetics and Pharmacodynamics in Postmenopausal Participants With Moderate to Sever Vulvar and Vaginal Atrophy",
                    "acronym": "DARE-VVA1"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-07",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2021-11-22",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2022-12-20",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2023-03-01",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2022-05-02",
                    "studyFirstSubmitQcDate": "2022-05-12",
                    "studyFirstPostDateStruct": {
                        "date": "2022-05-18",
                        "type": "ACTUAL"
                    },
                    "resultsFirstSubmitDate": "2023-08-21",
                    "resultsFirstSubmitQcDate": "2024-07-29",
                    "resultsFirstPostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-07-29",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Dar\u00e9 Bioscience, Inc.",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": false,
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "The purpose of the study is to study the safety, PK and PD of Intravaginal Tamoxifen on postmenopausal women with vulvar vaginal atrophy."
                },
                "conditionsModule": {
                    "conditions": [
                        "Vulvar Atrophy"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE1",
                        "PHASE2"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "BASIC_SCIENCE",
                        "maskingInfo": {
                            "masking": "QUADRUPLE",
                            "whoMasked": [
                                "PARTICIPANT",
                                "CARE_PROVIDER",
                                "INVESTIGATOR",
                                "OUTCOMES_ASSESSOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 17,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Placebo",
                            "type": "PLACEBO_COMPARATOR",
                            "description": "Vaginal insert",
                            "interventionNames": [
                                "Other: Placebo"
                            ]
                        },
                        {
                            "label": "DARE-VVA1 1mg",
                            "type": "EXPERIMENTAL",
                            "description": "vaginal insert",
                            "interventionNames": [
                                "Drug: Tamoxifen"
                            ]
                        },
                        {
                            "label": "DARE-VVA1 5mg",
                            "type": "EXPERIMENTAL",
                            "description": "vaginal insert",
                            "interventionNames": [
                                "Drug: Tamoxifen"
                            ]
                        },
                        {
                            "label": "DARE-VVA1 10mg",
                            "type": "EXPERIMENTAL",
                            "description": "vaginal insert",
                            "interventionNames": [
                                "Drug: Tamoxifen"
                            ]
                        },
                        {
                            "label": "DARE-VVA1 20mg",
                            "type": "EXPERIMENTAL",
                            "description": "vaginal insert",
                            "interventionNames": [
                                "Drug: Tamoxifen"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "Tamoxifen",
                            "description": "Tamoxifen vaginal insert",
                            "armGroupLabels": [
                                "DARE-VVA1 10mg",
                                "DARE-VVA1 1mg",
                                "DARE-VVA1 20mg",
                                "DARE-VVA1 5mg"
                            ]
                        },
                        {
                            "type": "OTHER",
                            "name": "Placebo",
                            "description": "Placebo vaginal insert",
                            "armGroupLabels": [
                                "Placebo"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Number of Subjects With Treatment Emergent Adverse Events",
                            "description": "to evaluate the safety and tolerability of DARE-VVA1 by intravaginal administration",
                            "timeFrame": "56 days"
                        },
                        {
                            "measure": "Concentration of Tamoxifen in Serial Plasma Collections (Cmax)",
                            "description": "to determine the plasma concentrations of tamoxifen after intravaginal administration",
                            "timeFrame": "56 days"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Evaluation of Vaginal Cytology",
                            "description": "to analyze the change from baseline to end of study of percentage of parabasal cells",
                            "timeFrame": "56 days"
                        },
                        {
                            "measure": "Evaluation of Vaginal pH",
                            "description": "to analyze preliminary efficacy and pharmacodynamics of DARE-VVA1 by looking at change in baseline of vaginal pH from Day 1 to Day 56",
                            "timeFrame": "56 days"
                        },
                        {
                            "measure": "Evaluation of Vaginal Cytology",
                            "description": "to analyze the change from baseline to end of study of percentage of superficial cells",
                            "timeFrame": "56 days"
                        }
                    ],
                    "otherOutcomes": [
                        {
                            "measure": "Collection of Menopause-specific Quality of Life (MENQOL) Questionnaire",
                            "description": "to analyze the impact of DARE-VVA1 on quality of life following treatment evaluated by total questionnaire score; looking for a decreased in total score.",
                            "timeFrame": "56 days"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* 1. Women aged 40-75 (inclusive).\n\n  2. Postmenopausal women with a body mass index between 18 and 34 kg/m2, inclusive.\n\n  3. Postmenopausal, defined as 12 months of spontaneous amenorrhea or 6 months of spontaneous amenorrhea with serum follicle-stimulating hormone levels \\> 40 mIU/mL or 6 weeks post-surgical bilateral oophorectomy.\n\n  4. Have moderate to severe VVA as determined by self-assessment of the following symptoms (as none, mild, moderate, or severe), with at least 1 symptom reported as moderate or severe: vaginal dryness; vaginal and/or vulvar irritation/itching; dysuria; vaginal pain with sexual activity (dyspareunia); vaginal bleeding associated with sexual activity (presence versus absence).\n\n  5. Women who currently have vaginal intercourse or other sexual activity (masturbation, etc.) at least once a month (with or without a partner), or who had intercourse or other sexual activity at least once a month in the past, but later decreased sexual activity due to excessive pain or vaginal dryness. Participants must be willing to engage in vaginal intercourse or other sexual activity (masturbation, etc.) at least 1 time between Days 49-56 of the clinical study.\n\n  6. Participants, upon pelvic examination with speculum examination, must have a normal-appearing vulva other than atrophic changes, normal-appearing cervix other than atrophic changes (i.e., cervical stenosis and/or flushness with the vaginal wall) and normal-appearing vagina (without erosions, ulcerations, scarring, or evidence of dermatoses) other than atrophic changes (loss of ruggae, mucosal pallor, mucosal dryness, mucosal petechiae).\n\n  7. Have an intact uterus and no prior history of endometrial ablation.\n\n  8. Vaginal cellular cytology with \u2264 5% superficial cells.\n\n  9. Vaginal pH \\> 5 at Screening Visit.\n\n  10. Endometrial thickness \u2264 4 mm on transvaginal ultrasound.\n\n  11. Current on all recommended screening and management requirements for cervical cancer.\n\n  12. Normal mammogram report within 2 years of screening.\n\n  13. Normal manual breast examination by investigator at baseline.\n\n  14. Baseline hematology, clinical chemistry, urinalysis, prothrombin time/partial thromboplastin time (PT/PTT) and viral serologies for human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B surface antigen (HBsAg) all within normal limits OR accepted by the investigator and medical monitor as not clinically significant.\n\n  15. Normal 12-lead electrocardiogram (ECG).\n\n  16. Able to read, understand, and provide written informed consent and applicable data protection authorization after the nature of the study has been fully explained, and must be willing to comply with all study requirements.\n\n  17. Willing and able to correctly and independently complete all study procedures.\n\nExclusion Criteria:\n\n1. A history of or physical examination finding for any significant cardiovascular, renal, pulmonary, neurological and hepatic diseases preventing compliance with this study.\n2. A medical history of or use of anticoagulant drugs to treat or prevent coagulopathies, thrombophilia or thromboembolic disease (deep vein thrombosis, pulmonary or systemic embolism, stroke, or transient ischemic attack).\n3. Uncontrolled hypertension (either systolic \\> 180 mmHg or diastolic \\> 105 mmHg), treatment with Class 1 antiarrhythmics or digitalis, history of congestive heart failure (New York Heart Association \\[NYHA\\] \\> Class I), or myocardial infarction within 12 months.\n4. Abnormal cervical screening test within 2 years of screening. Participant can have atypical squamous cells of undetermined significance if human papilloma virus-negative.\n5. History of or current endometrial pathology: hyperplasia, carcinoma and/or polyp (prior history of a benign endometrial polyp with no current evidence of polyp is acceptable).\n6. A medical history of breast cancer within 5 years of screening. Participants with a history of breast cancer more than 5 years prior to screening are considered eligible if their disease was node-negative, nonmetastatic, and if all treatment with aromatase inhibitors (AIs) or SERMs was completed at least 6 months prior to screening.\n7. A medical history of malignant melanoma.\n8. Any cancer (except nonmelanomatous skin cancer) diagnosed less than 5 years prior to the Screening Visit.\n9. A medical history of undiagnosed vaginal bleeding.\n10. A known or suspected estrogen-dependent neoplasia.\n11. Previous radiation treatment to the pelvis.\n12. Women who have previously reported an unsatisfactory outcome from a vaginal hormone therapy for VVA.\n13. Known hypersensitivity to any ingredients in DARE-VVA1.\n14. Use of vaginal hormonal products (rings, creams, gels, tablets, capsules) within 4 weeks prior to Day 1.\n15. Use of transdermal estrogen or transdermal estrogen/progestin products within 4 weeks prior to Day 1.\n16. Use of oral estrogen and/or progestin therapy within 8 weeks prior to Day 1.\n17. Use of intrauterine progestin therapy within 8 weeks prior to Day 1.\n18. Use of progestin implants or estrogen-alone injectable drug therapy within 12 weeks prior to Day 1.\n19. Administration of estrogen pellet therapy or progestin injectable drug therapy within 6 months prior to Day 1.\n20. Use of thyroid hormone replacement therapy unless the participant is on a stable dose for \\> 6 months, and participant is euthyroid based on a normal, sensitive immunoassay for thyroid-stimulating hormone (TSH).\n21. Use of SERMs or AIs within 6 months prior to screening.\n22. Use of anabolic or other steroids (including hormonal creams such as testosterone) within 4 weeks prior to Day 1.\n23. Use of corticosteroids, \\> 5 mg/day prednisone or equivalent, for more than 4 weeks within 4 weeks prior to Day 1.\n24. Participants with any self-reported active sexually transmitted disease and/or evidence of infection (including bacterial vaginosis) on vaginal examination by the investigator.\n25. Participants with a urinary tract infection during screening as assessed by urine dipstick test with abnormal test findings (any positive result for leukocytes AND any positive result for nitrites).\n26. Presence of clinically significant uterine fibroids.\n27. Evidence of current alcohol or drug abuse in the past 60 days, including a positive result from the urine drugs of abuse or alcohol screen, or history of drug or alcohol dependence in the last 2 years, as assessed by the investigator. Alcohol abuse is defined as greater than 14 standard units/week for females, and drug abuse is defined as known psychiatric or substance abuse disorder that would interfere with participation with the requirements of this study, including current use of any illicit drugs. Use of medical cannabis is not exclusionary.\n28. Participation in any other investigational drug or device trial in which administration of an investigational study drug/device occurred within 30 days or placement of a non-drug eluting medical device within 15 days prior to the Screening Visit (Visit 1).\n29. In the opinion of the investigator, participant has any disorder or finding that might interfere with the conduct of the study.",
                    "healthyVolunteers": true,
                    "sex": "FEMALE",
                    "minimumAge": "40 Years",
                    "maximumAge": "75 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "locations": [
                        {
                            "facility": "PARC Clinical Research",
                            "city": "Adelaide",
                            "state": "Southern Australia",
                            "zip": "5000",
                            "country": "Australia",
                            "geoPoint": {
                                "lat": -34.92866,
                                "lon": 138.59863
                            }
                        },
                        {
                            "facility": "Keogh Institute for Medical Research",
                            "city": "Nedlands",
                            "state": "Western Australia",
                            "zip": "6009",
                            "country": "Australia",
                            "geoPoint": {
                                "lat": -31.98184,
                                "lon": 115.8073
                            }
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO",
                    "description": "A decision has not yet been made on when or what IPD to share when available."
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "Placebo",
                            "description": "Vaginal insert\n\nPlacebo: Placebo vaginal insert"
                        },
                        {
                            "id": "FG001",
                            "title": "DARE-VVA1 1mg",
                            "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                        },
                        {
                            "id": "FG002",
                            "title": "DARE-VVA1 5mg",
                            "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                        },
                        {
                            "id": "FG003",
                            "title": "DARE-VVA1 10mg",
                            "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                        },
                        {
                            "id": "FG004",
                            "title": "DARE-VVA1 20mg",
                            "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "4"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "4"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG004",
                                            "numSubjects": "3"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "3"
                                        },
                                        {
                                            "groupId": "FG004",
                                            "numSubjects": "3"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG004",
                                            "numSubjects": "0"
                                        }
                                    ]
                                }
                            ],
                            "dropWithdraws": [
                                {
                                    "type": "Protocol Violation",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "1"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG003",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG004",
                                            "numSubjects": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "Placebo",
                            "description": "Vaginal insert\n\nPlacebo: Placebo vaginal insert"
                        },
                        {
                            "id": "BG001",
                            "title": "DARE-VVA1 1mg",
                            "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                        },
                        {
                            "id": "BG002",
                            "title": "DARE-VVA1 5mg",
                            "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                        },
                        {
                            "id": "BG003",
                            "title": "DARE-VVA1 10mg",
                            "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                        },
                        {
                            "id": "BG004",
                            "title": "DARE-VVA1 20mg",
                            "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                        },
                        {
                            "id": "BG005",
                            "title": "Total",
                            "description": "Total of all reporting groups"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "4"
                                },
                                {
                                    "groupId": "BG001",
                                    "value": "3"
                                },
                                {
                                    "groupId": "BG002",
                                    "value": "4"
                                },
                                {
                                    "groupId": "BG003",
                                    "value": "3"
                                },
                                {
                                    "groupId": "BG004",
                                    "value": "3"
                                },
                                {
                                    "groupId": "BG005",
                                    "value": "17"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Categorical",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "<=18 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Between 18 and 65 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "12"
                                                }
                                            ]
                                        },
                                        {
                                            "title": ">=65 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "5"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Age, Continuous",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "years",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "61.3",
                                                    "spread": "5.38"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "65.7",
                                                    "spread": "1.53"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "59.3",
                                                    "spread": "2.99"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "57.7",
                                                    "spread": "8.08"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "61.3",
                                                    "spread": "4.16"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "60.9",
                                                    "spread": "4.97"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "17"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Ethnicity (NIH/OMB)",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Hispanic or Latino",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Not Hispanic or Latino",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "17"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Unknown or Not Reported",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Race (NIH/OMB)",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "American Indian or Alaska Native",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Asian",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Native Hawaiian or Other Pacific Islander",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Black or African American",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "White",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "17"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "More than one race",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Unknown or Not Reported",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Region of Enrollment",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "participants",
                            "classes": [
                                {
                                    "title": "Australia",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "17"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Body Mass Index",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "kg/m^2",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "25.03",
                                                    "spread": "5.287"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "26.04",
                                                    "spread": "4.869"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "26.58",
                                                    "spread": "5.486"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "24.67",
                                                    "spread": "2.219"
                                                },
                                                {
                                                    "groupId": "BG004",
                                                    "value": "23.70",
                                                    "spread": "3.676"
                                                },
                                                {
                                                    "groupId": "BG005",
                                                    "value": "25.27",
                                                    "spread": "4.151"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Number of Subjects With Treatment Emergent Adverse Events",
                            "description": "to evaluate the safety and tolerability of DARE-VVA1 by intravaginal administration",
                            "reportingStatus": "POSTED",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "timeFrame": "56 days",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Placebo",
                                    "description": "Vaginal insert\n\nPlacebo: Placebo vaginal insert"
                                },
                                {
                                    "id": "OG001",
                                    "title": "DARE-VVA1 1mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                },
                                {
                                    "id": "OG002",
                                    "title": "DARE-VVA1 5mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                },
                                {
                                    "id": "OG003",
                                    "title": "DARE-VVA1 10mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                },
                                {
                                    "id": "OG004",
                                    "title": "DARE-VVA1 20mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "3"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "OG003",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "OG004",
                                                    "value": "3"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "PRIMARY",
                            "title": "Concentration of Tamoxifen in Serial Plasma Collections (Cmax)",
                            "description": "to determine the plasma concentrations of tamoxifen after intravaginal administration",
                            "populationDescription": "Placebo users were not using Tamoxifen so a correlation between Tamoxifen and vaginal pH was not performed.",
                            "reportingStatus": "POSTED",
                            "paramType": "GEOMETRIC_MEAN",
                            "dispersionType": "Geometric Coefficient of Variation",
                            "unitOfMeasure": "ng/mL",
                            "timeFrame": "56 days",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Placebo",
                                    "description": "placebo vaginal insert"
                                },
                                {
                                    "id": "OG001",
                                    "title": "DARE-VVA1 1mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                },
                                {
                                    "id": "OG002",
                                    "title": "DARE-VVA1 5mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                },
                                {
                                    "id": "OG003",
                                    "title": "DARE-VVA1 10mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                },
                                {
                                    "id": "OG004",
                                    "title": "DARE-VVA1 20mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "3"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0",
                                                    "spread": "0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.181",
                                                    "spread": "32.21"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "1.93",
                                                    "spread": "46.62"
                                                },
                                                {
                                                    "groupId": "OG003",
                                                    "value": "3.29",
                                                    "spread": "12.01"
                                                },
                                                {
                                                    "groupId": "OG004",
                                                    "value": "5.50",
                                                    "spread": "31.54"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Evaluation of Vaginal Cytology",
                            "description": "to analyze the change from baseline to end of study of percentage of parabasal cells",
                            "populationDescription": "We were looking at a correlation between Tamoxifen and parabasal cells. Placebo users were not exposed to Tamoxifen.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Full Range",
                            "unitOfMeasure": "% parabasal cells",
                            "timeFrame": "56 days",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Placebo",
                                    "description": "placebo vaginal insert"
                                },
                                {
                                    "id": "OG001",
                                    "title": "DARE-VVA1 1mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                },
                                {
                                    "id": "OG002",
                                    "title": "DARE-VVA1 5mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                },
                                {
                                    "id": "OG003",
                                    "title": "DARE-VVA1 10mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                },
                                {
                                    "id": "OG004",
                                    "title": "DARE-VVA1 20mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "3"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0",
                                                    "lowerLimit": "0",
                                                    "upperLimit": "0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-12.0",
                                                    "lowerLimit": "-15",
                                                    "upperLimit": "-5"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-22.5",
                                                    "lowerLimit": "-45",
                                                    "upperLimit": "0"
                                                },
                                                {
                                                    "groupId": "OG003",
                                                    "value": "-69.0",
                                                    "lowerLimit": "-98",
                                                    "upperLimit": "-61"
                                                },
                                                {
                                                    "groupId": "OG004",
                                                    "value": "-94.0",
                                                    "lowerLimit": "-100",
                                                    "upperLimit": "-04"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Evaluation of Vaginal pH",
                            "description": "to analyze preliminary efficacy and pharmacodynamics of DARE-VVA1 by looking at change in baseline of vaginal pH from Day 1 to Day 56",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Standard Deviation",
                            "unitOfMeasure": "pH",
                            "timeFrame": "56 days",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Placebo",
                                    "description": "Vaginal insert\n\nPlacebo: Placebo vaginal insert"
                                },
                                {
                                    "id": "OG001",
                                    "title": "DARE-VVA1 1mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                },
                                {
                                    "id": "OG002",
                                    "title": "DARE-VVA1 5mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                },
                                {
                                    "id": "OG003",
                                    "title": "DARE-VVA1 10mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                },
                                {
                                    "id": "OG004",
                                    "title": "DARE-VVA1 20mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "3"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-0.3",
                                                    "spread": "0.95"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.3",
                                                    "spread": "0.31"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-0.3",
                                                    "spread": "0.42"
                                                },
                                                {
                                                    "groupId": "OG003",
                                                    "value": "-0.3",
                                                    "spread": "0.70"
                                                },
                                                {
                                                    "groupId": "OG004",
                                                    "value": "-0.7",
                                                    "spread": "0.72"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Evaluation of Vaginal Cytology",
                            "description": "to analyze the change from baseline to end of study of percentage of superficial cells",
                            "populationDescription": "We were looking at a correlation between Tamoxifen and superficial cells. Placebo users were not exposed to Tamoxifen.",
                            "reportingStatus": "POSTED",
                            "paramType": "MEAN",
                            "dispersionType": "Full Range",
                            "unitOfMeasure": "% superficial cells",
                            "timeFrame": "56 days",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Placebo",
                                    "description": "placebo vaginal insert"
                                },
                                {
                                    "id": "OG001",
                                    "title": "DARE-VVA1 1mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                },
                                {
                                    "id": "OG002",
                                    "title": "DARE-VVA1 5mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                },
                                {
                                    "id": "OG003",
                                    "title": "DARE-VVA1 10mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                },
                                {
                                    "id": "OG004",
                                    "title": "DARE-VVA1 20mg",
                                    "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "3"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0",
                                                    "lowerLimit": "0",
                                                    "upperLimit": "0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-3.0",
                                                    "lowerLimit": "-4",
                                                    "upperLimit": "-2"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "8.5",
                                                    "lowerLimit": "2",
                                                    "upperLimit": "15"
                                                },
                                                {
                                                    "groupId": "OG003",
                                                    "value": "6.0",
                                                    "lowerLimit": "1",
                                                    "upperLimit": "14"
                                                },
                                                {
                                                    "groupId": "OG004",
                                                    "value": "52.3",
                                                    "lowerLimit": "18",
                                                    "upperLimit": "85"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "OTHER_PRE_SPECIFIED",
                            "title": "Collection of Menopause-specific Quality of Life (MENQOL) Questionnaire",
                            "description": "to analyze the impact of DARE-VVA1 on quality of life following treatment evaluated by total questionnaire score; looking for a decreased in total score.",
                            "reportingStatus": "NOT_POSTED",
                            "timeFrame": "56 days",
                            "denomUnitsSelected": "Participants"
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "0",
                    "timeFrame": "56 days",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "Placebo",
                            "description": "Vaginal insert\n\nPlacebo: Placebo vaginal insert",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 4,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 4,
                            "otherNumAffected": 3,
                            "otherNumAtRisk": 4
                        },
                        {
                            "id": "EG001",
                            "title": "DARE-VVA1 1mg",
                            "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 3,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 3,
                            "otherNumAffected": 2,
                            "otherNumAtRisk": 3
                        },
                        {
                            "id": "EG002",
                            "title": "DARE-VVA1 5mg",
                            "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 4,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 4,
                            "otherNumAffected": 4,
                            "otherNumAtRisk": 4
                        },
                        {
                            "id": "EG003",
                            "title": "DARE-VVA1 10mg",
                            "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 3,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 3,
                            "otherNumAffected": 3,
                            "otherNumAtRisk": 3
                        },
                        {
                            "id": "EG004",
                            "title": "DARE-VVA1 20mg",
                            "description": "vaginal insert\n\nTamoxifen: Tamoxifen vaginal insert",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 3,
                            "seriousNumAffected": 0,
                            "seriousNumAtRisk": 3,
                            "otherNumAffected": 3,
                            "otherNumAtRisk": 3
                        }
                    ],
                    "otherEvents": [
                        {
                            "term": "Vulvovaginal discomfort",
                            "organSystem": "Reproductive system and breast disorders",
                            "sourceVocabulary": "MedDra (25.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG003",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG004",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 3
                                }
                            ]
                        },
                        {
                            "term": "Vulvovaginal pruritis",
                            "organSystem": "Reproductive system and breast disorders",
                            "sourceVocabulary": "MedDra (25.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG003",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG004",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 3
                                }
                            ]
                        },
                        {
                            "term": "Genital rash",
                            "organSystem": "Reproductive system and breast disorders",
                            "sourceVocabulary": "MedDra (25.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG003",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG004",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                }
                            ]
                        },
                        {
                            "term": "Postmenopausal hemorrhage",
                            "organSystem": "Reproductive system and breast disorders",
                            "sourceVocabulary": "MedDra (25.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG003",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG004",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                }
                            ]
                        },
                        {
                            "term": "Vulvovaginal erythema",
                            "organSystem": "Reproductive system and breast disorders",
                            "sourceVocabulary": "MedDra (25.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG003",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG004",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                }
                            ]
                        },
                        {
                            "term": "Headache",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDra (25.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG003",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG004",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 3
                                }
                            ]
                        },
                        {
                            "term": "Dizziness",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDra (25.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 2,
                                    "numAffected": 2,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG003",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG004",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                }
                            ]
                        },
                        {
                            "term": "Migraine",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDra (25.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG003",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG004",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                }
                            ]
                        },
                        {
                            "term": "Sciatica",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDra (25.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG003",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG004",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                }
                            ]
                        },
                        {
                            "term": "Hot flush",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDra (25.0)",
                            "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG001",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG002",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 4
                                },
                                {
                                    "groupId": "EG003",
                                    "numEvents": 1,
                                    "numAffected": 1,
                                    "numAtRisk": 3
                                },
                                {
                                    "groupId": "EG004",
                                    "numEvents": 0,
                                    "numAffected": 0,
                                    "numAtRisk": 3
                                }
                            ]
                        }
                    ]
                },
                "moreInfoModule": {
                    "limitationsAndCaveats": {
                        "description": "The study enrollment proved difficult and lead to small numbers of subjects analyzed per arm."
                    },
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictionType": "OTHER",
                        "restrictiveAgreement": true,
                        "otherDetails": "PI is not able to publish study data without prior approval from Sponsor."
                    },
                    "pointOfContact": {
                        "title": "Jessica Hatheway, VP Clinical Operations",
                        "organization": "Dare Bioscience, Inc.",
                        "email": "jhatheway@darebioscience.com",
                        "phone": "858-926-7655"
                    }
                }
            },
            "documentSection": {
                "largeDocumentModule": {
                    "largeDocs": [
                        {
                            "typeAbbrev": "Prot_SAP",
                            "hasProtocol": true,
                            "hasSap": true,
                            "hasIcf": false,
                            "label": "Study Protocol and Statistical Analysis Plan",
                            "date": "2022-04-04",
                            "uploadDate": "2023-08-21T14:22",
                            "filename": "Prot_SAP_000.pdf",
                            "size": 1027917
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D001284",
                            "term": "Atrophy"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D020763",
                            "term": "Pathological Conditions, Anatomical"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M4589",
                            "name": "Atrophy",
                            "asFound": "Atrophy",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M22519",
                            "name": "Pathological Conditions, Anatomical",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D013629",
                            "term": "Tamoxifen"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D004965",
                            "term": "Estrogen Antagonists"
                        },
                        {
                            "id": "D006727",
                            "term": "Hormone Antagonists"
                        },
                        {
                            "id": "D006730",
                            "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                        },
                        {
                            "id": "D045505",
                            "term": "Physiological Effects of Drugs"
                        },
                        {
                            "id": "D018931",
                            "term": "Antineoplastic Agents, Hormonal"
                        },
                        {
                            "id": "D000970",
                            "term": "Antineoplastic Agents"
                        },
                        {
                            "id": "D020845",
                            "term": "Selective Estrogen Receptor Modulators"
                        },
                        {
                            "id": "D020847",
                            "term": "Estrogen Receptor Modulators"
                        },
                        {
                            "id": "D050071",
                            "term": "Bone Density Conservation Agents"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M16403",
                            "name": "Tamoxifen",
                            "asFound": "Specified",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M8116",
                            "name": "Estrogens",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8114",
                            "name": "Estrogen Antagonists",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M30483",
                            "name": "Estrogen Receptor Antagonists",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9789",
                            "name": "Hormones",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9788",
                            "name": "Hormone Antagonists",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20966",
                            "name": "Antineoplastic Agents, Hormonal",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M22599",
                            "name": "Estrogen Receptor Modulators",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M22597",
                            "name": "Selective Estrogen Receptor Modulators",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BDCA",
                            "name": "Bone Density Conservation Agents"
                        },
                        {
                            "abbrev": "ANeo",
                            "name": "Antineoplastic Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT06649669",
                    "orgStudyIdInfo": {
                        "id": "ADC-US-RES-24259"
                    },
                    "organization": {
                        "fullName": "[Redacted]"
                    },
                    "briefTitle": "[Trial of device that is not approved or cleared by the U.S. FDA]",
                    "officialTitle": "[Trial of device that is not approved or cleared by the U.S. FDA]"
                },
                "statusModule": {
                    "overallStatus": "WITHHELD",
                    "delayedPosting": true,
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "studyFirstSubmitDate": "2024-10-17",
                    "studyFirstSubmitQcDate": "2024-10-17",
                    "studyFirstPostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-17",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "oldNameTitle": "[Redacted]",
                        "oldOrganization": "[Redacted]"
                    },
                    "leadSponsor": {
                        "name": "[Redacted]"
                    }
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT06550440",
                    "orgStudyIdInfo": {
                        "id": "20240712"
                    },
                    "organization": {
                        "fullName": "Children's Hospital of Fudan University",
                        "class": "OTHER"
                    },
                    "briefTitle": "The Impact of Family Integrated Care on Extrauterine Growth Restriction at Discharge in Very Low Birth Weight Infants",
                    "officialTitle": "The Impact of Family Integrated Care on the Occurrence of Extrauterine Growth Restriction at Discharge in Very Low Birth Weight Infants: a Multicenter, Retrospective Case-control Study"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2021-02-01",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2023-11-30",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2024-05-01",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2024-08-06",
                    "studyFirstSubmitQcDate": "2024-08-11",
                    "studyFirstPostDateStruct": {
                        "date": "2024-08-13",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-17",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Children's Hospital of Fudan University",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "To explore the influence of multi-angle factors, including family integrated care, on extrauterine growth restriction at discharge of very low birth weight infants.",
                    "detailedDescription": "To explore the influence of multi-angle factors, including family integrated care, on extrauterine growth restriction at discharge of very low birth weight infants.Very low birth weight infants admitted to 17 neonatal intensive care units in 8 provinces and cities in southeast China from February 2021 to November 2023 were retrospectively included, which were divided into case group and control group according to whether there was extrauterine growth restriction (defined as the weight below the 10th percentile of children of the same age at discharge). The general situation at birth, the length of hospital stay, the incidence of complications during hospital stay, the feeding situation, the length of family participation care and the perinatal situation of the mother were compared between the two groups. The generalized linear mixed model was used to analyze the influencing factors of extrauterine growth retardation at discharge, and the results of influencing factors were visualized by GraphPad Prism 9.0 software."
                },
                "conditionsModule": {
                    "conditions": [
                        "Very Low Birth Weight Infant"
                    ],
                    "keywords": [
                        "very low birth weight infants",
                        "family integrated care"
                    ]
                },
                "designModule": {
                    "studyType": "OBSERVATIONAL",
                    "patientRegistry": false,
                    "designInfo": {
                        "observationalModel": "CASE_CONTROL",
                        "timePerspective": "RETROSPECTIVE"
                    },
                    "enrollmentInfo": {
                        "count": 1255,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "the control group",
                            "description": "Very low birth weight infants without extrauterine growth restriction at discharge.",
                            "interventionNames": [
                                "Behavioral: family integrated care"
                            ]
                        },
                        {
                            "label": "the case group",
                            "description": "Very low birth weight infants with extrauterine growth restriction at discharge.",
                            "interventionNames": [
                                "Behavioral: family integrated care"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "BEHAVIORAL",
                            "name": "family integrated care",
                            "description": "Trained NICU nurses give effective education to parents of children, and regard parents as a part of NICU team, so that they can actively provide positive care for babies instead of passive caregivers. Parents mainly participate in nursing care such as bottle feeding, changing diapers, skin contact and so on.",
                            "armGroupLabels": [
                                "the case group",
                                "the control group"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "total duration of family integrated care",
                            "description": "Trained NICU staffs effectively educate parents as part of the NICU team so that they can proactively provide active care for the baby, rather than passive caregivers. Parents are primarily involved in care such as bottle feeding, diaper changing, skin-to-skin contact and so on.We calculate total duration of family integrated care in hours.",
                            "timeFrame": "From the day admitted into the NICU until day on discharge\uff0can average of 2 months."
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Birth weight",
                            "description": "birth weight in grams",
                            "timeFrame": "assessed at birth."
                        },
                        {
                            "measure": "Small for gestational age",
                            "description": "birth weight\\<10th percentile of the neonatal growth curve for infants of the same sex and gestational age",
                            "timeFrame": "assessed at birth."
                        },
                        {
                            "measure": "Necrotizing enterocolitis",
                            "description": "diagnosed according to the Bella classification",
                            "timeFrame": "From the day admitted into the NICU until day on discharge, an average of 2 months."
                        },
                        {
                            "measure": "gestational age",
                            "description": "gestational age at weeks",
                            "timeFrame": "assessed at birth."
                        }
                    ],
                    "otherOutcomes": [
                        {
                            "measure": "Bronchopulmonary dysplasia",
                            "description": "oxygen is required at 36 weeks of corrected gestational age or at discharge",
                            "timeFrame": "From the day admitted into the NICU until day on discharge\uff0can average of 2 months."
                        },
                        {
                            "measure": "Retinopathy of prematurity",
                            "description": "diagnosed according to the International Classification of Retinopathy of Prematurity",
                            "timeFrame": "From the day admitted into the NICU until day on discharge, an average of 2 months."
                        },
                        {
                            "measure": "Intraventricular hemorrhage",
                            "description": "the diagnosis is based on Paplie's classification",
                            "timeFrame": "From the day admitted into the NICU until day on discharge\uff0can average of 2 months."
                        },
                        {
                            "measure": "Late-onset sepsis",
                            "description": "sepsis occurs \\>72h after birth",
                            "timeFrame": "From the day admitted into the NICU until day on discharge, an average of 2 months."
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Newborns admitted to 17 units in 8 provinces from February 2021 to November 2023;\n2. Birth weight \\< 1500 g, gestational age \\< 32 weeks;\n3. admitted in NICU within 24 hours after birth;\n4. premature infants without complications (including bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis, intraventricular hemorrhage and late-onset septicemia) at the time of admission.\n\nExclusion Criteria:\n\n1. death occurred during hospitalization;\n2. Incomplete outcome data (lack of EUGR data at discharge).",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "28 Weeks",
                    "maximumAge": "32 Weeks",
                    "stdAges": [
                        "CHILD"
                    ],
                    "studyPopulation": "very low birth weight infants",
                    "samplingMethod": "NON_PROBABILITY_SAMPLE"
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Xiaojing Hu, PhD",
                            "affiliation": "Children's Hospital of Fudan University",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Children's Hospital of Fudan University",
                            "city": "Shanghai",
                            "state": "Shanghai",
                            "zip": "200032",
                            "country": "China",
                            "geoPoint": {
                                "lat": 31.22222,
                                "lon": 121.45806
                            }
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D001835",
                            "term": "Body Weight"
                        },
                        {
                            "id": "D001724",
                            "term": "Birth Weight"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M5114",
                            "name": "Body Weight",
                            "asFound": "Weight",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M5006",
                            "name": "Birth Weight",
                            "asFound": "Birth Weight",
                            "relevance": "HIGH"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT05123040",
                    "orgStudyIdInfo": {
                        "id": "2020LS098"
                    },
                    "secondaryIdInfos": [
                        {
                            "id": "MT2020-28",
                            "type": "OTHER",
                            "domain": "Masonic Cancer Center"
                        }
                    ],
                    "organization": {
                        "fullName": "Masonic Cancer Center, University of Minnesota",
                        "class": "OTHER"
                    },
                    "briefTitle": "Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids",
                    "officialTitle": "Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids for Treatment of Minnesota High-Risk Acute GVHD (aGVHD): A Phase I/II Study"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2023-06-05",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2025-09",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2028-09",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2021-11-03",
                    "studyFirstSubmitQcDate": "2021-11-04",
                    "studyFirstPostDateStruct": {
                        "date": "2021-11-17",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-17",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Masonic Cancer Center, University of Minnesota",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": true,
                    "isFdaRegulatedDrug": true,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "This multi-center center phase I/II study to establish the lowest possible recommended phase 2 dose (RP2D) of corticosteroids in conjunction with ruxolitinib and uhCG/EGF (a novel combination) for high-risk aGVHD.\n\nThis is a single arm study designed to determine the lowest dose of corticosteroids required (toxicity endpoint) without impairing GVHD complete response or partial response (CR/PR) at day 28 when given in conjunction with uhCG/EGF and ruxolitinib.\n\nAfter completion of the corticosteroid dose finding, the final dose will be carried forward into a two-stage phase II extension trial to confirm safety and make a preliminary determination of efficacy of this novel drug combination for high-risk aGVHD."
                },
                "conditionsModule": {
                    "conditions": [
                        "Acute-graft-versus-host Disease"
                    ],
                    "keywords": [
                        "aGVHD"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE1",
                        "PHASE2"
                    ],
                    "designInfo": {
                        "allocation": "NA",
                        "interventionModel": "SINGLE_GROUP",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 55,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Ruxolitinib;hCG (Pregnyl\u00ae) ;Corticosteroids",
                            "type": "EXPERIMENTAL",
                            "description": "* Ruxolitinib 10 mg by mouth twice daily (with dose adjustments as indicated) through day 56, followed by taper\n* hCG (Pregnyl\u00ae) 2,000 units/m2 SQ every other day x 3 doses, followed by twice weekly x 14 doses (total 17 doses through day 56)\n* Corticosteroids (Prednisone, or IV methylprednisolone equivalent)\n\n  * Dose level 1 (starting dose) = 1 mg/kg\n  * Dose level 2 = 0.5 mg/kg\n  * Dose level 3 = 0.25 mg/kg\n  * Dose level 4 = 0.1 mg/kg\n  * Dose level 5 = 0 mg/kg",
                            "interventionNames": [
                                "Drug: Ruxolitinib 10 MG Oral Tablet",
                                "Drug: hCG",
                                "Drug: Corticosteroids"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "Ruxolitinib 10 MG Oral Tablet",
                            "description": "By mouth twice daily through day 56, then tapered",
                            "armGroupLabels": [
                                "Ruxolitinib;hCG (Pregnyl\u00ae) ;Corticosteroids"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "hCG",
                            "description": "2,000 units/m2 SQ every other day x 3 doses, followed by twice weekly x 14 doses",
                            "armGroupLabels": [
                                "Ruxolitinib;hCG (Pregnyl\u00ae) ;Corticosteroids"
                            ],
                            "otherNames": [
                                "Pregnyl"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Corticosteroids",
                            "description": "Dose level 1 (starting dose) = 1 mg/kg\n\n* Dose level 2 = 0.5 mg/kg\n* Dose level 3 = 0.25 mg/kg\n* Dose level 4 = 0.1 mg/kg\n* Dose level 5 = 0 mg/kg\n\n  \u2022 If dose level 1 is determined to be below the Recommended Phase 2 Dose (RP2D), the dose will be escalated:\n* Dose level -1 = 1.5 mg/kg\n* Dose level -2 = 2 mg/kg",
                            "armGroupLabels": [
                                "Ruxolitinib;hCG (Pregnyl\u00ae) ;Corticosteroids"
                            ],
                            "otherNames": [
                                "Prednisone",
                                "IV methylprednisolone"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Recommend the lowest possible dose for Phase II of corticosteroids when given in combination with ruxolitinib and uhCG/EGF in pediatric based on DLT frequency",
                            "description": "Plan report patients proportions and their 95% confidence intervals of paitents who experience dose limiting toxicity. Determine best dose based on DLT criteria by CTCAE v5.0\n\n* Thrombosis requiring anticoagulation\n* Ascites (grade 3-5)\n* Ovarian hyperstimulation syndrome",
                            "timeFrame": "28 days after therapy"
                        },
                        {
                            "measure": "Best response of treatment in adult and children",
                            "description": "proportions of complete, partial, mixed, and no response among surviving patients at days 28 after initiation of protocol therapy in pediatric and adult patients with Minnesota high-risk aGVHD",
                            "timeFrame": "28 days after therapy"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Number of participants with treatment-related adverse events as assessed by CTCAE v5.0",
                            "description": "Report any type of adverse event caused by a drug cause by dose of steroids in combination of ruxolitinib and uhCG/EGF.\n\nDue to the complex medical condition of the GVHD patient, monitoring for adverse events will focus on the following events beginning with the date consent is signed and continuing for 30 days after the subject has completed or discontinued from the study or has taken last dose of the study drug.\n\n* Rehospitalization\n* Death\n* Hematologic (grade 3-5 cytopenia)\n* Infections (grade 3-5)\n* Hyperglycemia (grade 3-5)\n* Steroid myopathy (grade 3-5)",
                            "timeFrame": "30 days after treatment"
                        },
                        {
                            "measure": "Incidence of acute GVHD flare after CR/PR requiring increase of steroids or other systemic treatment",
                            "description": "Find proportion of incidence of acute GVHD",
                            "timeFrame": "28 days after treatment"
                        },
                        {
                            "measure": "Incidence of acute GVHD flare after CR/PR requiring increase of steroids or other systemic treatment",
                            "description": "Find proportion of incidence of acute GVHD",
                            "timeFrame": "56 days after treatment"
                        },
                        {
                            "measure": "Compare the rate of treatment failure for acute GVHD after initiation of protocol therapy to historical controls",
                            "description": "Compare count of treatment failure to other number of failures in other historical protocols",
                            "timeFrame": "28 days after treatment"
                        },
                        {
                            "measure": "Compare the rate of treatment failure for acute GVHD after initiation of protocol therapy to historical controls",
                            "description": "Compare count of treatment failure to other number of failures in other historical protocols",
                            "timeFrame": "56 days after treatment"
                        },
                        {
                            "measure": "To assess patient quality of life on study",
                            "description": "Have participants take an overall survival survey",
                            "timeFrame": "6 month after treatment"
                        },
                        {
                            "measure": "Determine 1-year overall survival",
                            "description": "Provide proportions and their 95% confidence intervals of patients still alive at one year post-treatment",
                            "timeFrame": "1 year post treatment"
                        },
                        {
                            "measure": "Non-relapse mortality (death without recurrent or progressive disease after allo-HSCT)",
                            "description": "Provide proportions and their 95% confidence intervals of patients who expedience a non-relapse mortality.",
                            "timeFrame": "1 year post treatment"
                        },
                        {
                            "measure": "Collect blood samples and rectosigmoid biopsies for future correlative studies",
                            "description": "Give a count of the number of patients who had blood and rectosigmoid biopsies",
                            "timeFrame": "1 year after treament"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\nHCT recipients over 12 years of age within the first 7 days of initial treatment of high-risk aGVHD, defined as:\n\n* Newly diagnosed Minnesota high-risk aGVHD -OR-\n* Newly diagnosed Minnesota standard risk aGVHD with plasma amphiregulin \u2265 33 pg/ml tested at the UMN Cytokine Reference Lab. For amphiregulin lab ordering information, see Fairview Lab Guide: http://labguide.fairview.org/showtest.asp?testid=6766\\&format=long -OR-\n* Newly diagnosed Minnesota standard risk aGVHD Ann Arbor 3 biomarkers tested by Viracor. For ordering information, see: https://www.viracor-eurofins.com/test-menu/403572p-agvhd-symptomatic- onset-algorithm/\n\n  * Renal: Serum creatinine \u22642.5x upper limit of normal (ULN)\n  * Cardiac: Left ventricular ejection fraction (LVEF) \u2265 35%\n  * Voluntary written consent (adult or parent/guardian with minor assent for 12 through 17-year-olds).\n\nExclusion Criteria:\n\n* Progressive malignancy\n* Uncontrolled bacterial, fungal, parasitic, or viral infection at initiation of protocol treatment\n* Unwilling or unable to stop supplemental sex hormone therapy (estrogen, progesterone, and/or testosterone preparations)\n* Unwilling or unable to stop GnRH antagonists, aromatase inhibitors, or anti-androgens\n* History of a hormone responsive malignancy\n* Current thromboembolic disease requiring full-dose anticoagulation - patients receiving pharmacologic prophylaxis for thromboembolic disease will be eligible\n* Active or recent (within prior 3 months) thrombus, irrespective of anticoagulation status\n* Pregnancy\n* Women or men of childbearing potential unwilling to take adequate precautions to avoid unintended pregnancy from the start of protocol treatment through 30 days after the last treatment",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "12 Years",
                    "stdAges": [
                        "CHILD",
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "centralContacts": [
                        {
                            "name": "Cancer Center Clinical Trials Office",
                            "role": "CONTACT",
                            "phone": "612 624 2620",
                            "email": "ccinfo@umn.edu"
                        }
                    ],
                    "overallOfficials": [
                        {
                            "name": "Sherman Holtan, MD",
                            "affiliation": "Masonic Cancer Center, University of Minnesota",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Masonic Cancer Center at University of Minnesota",
                            "status": "RECRUITING",
                            "city": "Minneapolis",
                            "state": "Minnesota",
                            "zip": "55455",
                            "country": "United States",
                            "contacts": [
                                {
                                    "name": "Cancer Center Clinical Trials Office",
                                    "role": "CONTACT",
                                    "phone": "612-624-2620",
                                    "email": "ccinfo@umn.edu"
                                }
                            ],
                            "geoPoint": {
                                "lat": 44.97997,
                                "lon": -93.26384
                            }
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D006086",
                            "term": "Graft vs Host Disease"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D007154",
                            "term": "Immune System Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M9189",
                            "name": "Graft vs Host Disease",
                            "asFound": "Graft Versus Host Disease",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M10200",
                            "name": "Immune System Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T170",
                            "name": "Acute Graft Versus Host Disease",
                            "asFound": "Acute Graft Versus Host Disease",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "T2832",
                            "name": "Homologous Wasting Disease",
                            "asFound": "Graft Versus Host Disease",
                            "relevance": "HIGH"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC20",
                            "name": "Immune System Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "Rare",
                            "name": "Rare Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D011241",
                            "term": "Prednisone"
                        },
                        {
                            "id": "D008775",
                            "term": "Methylprednisolone"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000893",
                            "term": "Anti-Inflammatory Agents"
                        },
                        {
                            "id": "D005938",
                            "term": "Glucocorticoids"
                        },
                        {
                            "id": "D006728",
                            "term": "Hormones"
                        },
                        {
                            "id": "D006730",
                            "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                        },
                        {
                            "id": "D045505",
                            "term": "Physiological Effects of Drugs"
                        },
                        {
                            "id": "D018931",
                            "term": "Antineoplastic Agents, Hormonal"
                        },
                        {
                            "id": "D000970",
                            "term": "Antineoplastic Agents"
                        },
                        {
                            "id": "D000932",
                            "term": "Antiemetics"
                        },
                        {
                            "id": "D001337",
                            "term": "Autonomic Agents"
                        },
                        {
                            "id": "D018373",
                            "term": "Peripheral Nervous System Agents"
                        },
                        {
                            "id": "D005765",
                            "term": "Gastrointestinal Agents"
                        },
                        {
                            "id": "D018696",
                            "term": "Neuroprotective Agents"
                        },
                        {
                            "id": "D020011",
                            "term": "Protective Agents"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M11749",
                            "name": "Methylprednisolone",
                            "asFound": "Mental",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M1833",
                            "name": "Methylprednisolone Acetate",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M11750",
                            "name": "Methylprednisolone Hemisuccinate",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14120",
                            "name": "Prednisolone",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M229449",
                            "name": "Prednisolone acetate",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M211887",
                            "name": "Prednisolone hemisuccinate",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M248881",
                            "name": "Prednisolone phosphate",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14121",
                            "name": "Prednisone",
                            "asFound": "Technique",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M9168",
                            "name": "Chorionic Gonadotropin",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4217",
                            "name": "Anti-Inflammatory Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9047",
                            "name": "Glucocorticoids",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9789",
                            "name": "Hormones",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M9788",
                            "name": "Hormone Antagonists",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20966",
                            "name": "Antineoplastic Agents, Hormonal",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4251",
                            "name": "Antiemetics",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8881",
                            "name": "Gastrointestinal Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20773",
                            "name": "Neuroprotective Agents",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M21869",
                            "name": "Protective Agents",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "Infl",
                            "name": "Anti-Inflammatory Agents"
                        },
                        {
                            "abbrev": "AnEm",
                            "name": "Antiemetics"
                        },
                        {
                            "abbrev": "NeuroAg",
                            "name": "Neuroprotective Agents"
                        },
                        {
                            "abbrev": "Gast",
                            "name": "Gastrointestinal Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "ANeo",
                            "name": "Antineoplastic Agents"
                        },
                        {
                            "abbrev": "Repr",
                            "name": "Reproductive Control Agents"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT03587740",
                    "nctIdAliases": [
                        "NCT02414646"
                    ],
                    "orgStudyIdInfo": {
                        "id": "18-124"
                    },
                    "organization": {
                        "fullName": "Dana-Farber Cancer Institute",
                        "class": "OTHER"
                    },
                    "briefTitle": "ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer",
                    "officialTitle": "ATOP TRIAL: Adjuvant Ado-Trastuzumab Emtansine (T-DM1) for Older Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-09",
                    "overallStatus": "ACTIVE_NOT_RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2018-08-22",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2026-08-30",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2029-08-30",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2018-06-21",
                    "studyFirstSubmitQcDate": "2018-07-03",
                    "studyFirstPostDateStruct": {
                        "date": "2018-07-16",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-17",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "PRINCIPAL_INVESTIGATOR",
                        "investigatorFullName": "Rachel Freedman, MD, MPH",
                        "investigatorTitle": "Principal Investigator",
                        "investigatorAffiliation": "Dana-Farber Cancer Institute"
                    },
                    "leadSponsor": {
                        "name": "Dana-Farber Cancer Institute",
                        "class": "OTHER"
                    },
                    "collaborators": [
                        {
                            "name": "Susan G. Komen Breast Cancer Foundation",
                            "class": "OTHER"
                        },
                        {
                            "name": "Gateway for Cancer Research",
                            "class": "OTHER"
                        }
                    ]
                },
                "oversightModule": {
                    "oversightHasDmc": true,
                    "isFdaRegulatedDrug": true,
                    "isFdaRegulatedDevice": false,
                    "isUsExport": false
                },
                "descriptionModule": {
                    "briefSummary": "This research study is studying an investigational drug as a possible treatment for breast cancer that is positive for the protein Human Epidermal Growth Factor Receptor 2, also known as HER2-positive breast cancer.\n\nThe drug involved in this study is:\n\n-ado-trastuzumab emtansine (T-DM1)",
                    "detailedDescription": "This research study is a Phase II clinical trial. Phase II clinical trials test the safety and effectiveness of an investigational drug to learn whether the drug works in treating a specific disease. \"Investigational\" means that the drug is being studied and research doctors are trying to find out more about it-such as the safest dose to use and the side effects it may cause.\n\nThe purpose of this research study is to examine the long-term benefits of T-DM1 with regard to breast cancer and take a closer look at the side effects experienced by participants receiving T-DM1.\n\nThe FDA (the U.S. Food and Drug Administration) has not approved T-DM1 for use in patients with stage I, II, or III breast cancer, but it has been approved for use in advanced, previously treated, HER2-positive breast cancer.\n\nT-DM1 is an antibody-drug conjugate; it is made up of an antibody (trastuzumab) linked to a cytotoxic drug, DM1 (chemotherapy). T-DM1 functions as a targeted cancer therapy because it targets HER2-positive breast cancer cells directly, limiting exposure of the rest of the body to chemotherapy. More specifically, the trastuzumab in T-DM1 first binds to the HER2 protein on the surface of the breast cancer cells and the DM1 then enters the cells and can cause them to die, preventing tumor growth"
                },
                "conditionsModule": {
                    "conditions": [
                        "Breast Cancer"
                    ],
                    "keywords": [
                        "Breast Cancer"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE2"
                    ],
                    "designInfo": {
                        "allocation": "NA",
                        "interventionModel": "SINGLE_GROUP",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "NONE"
                        }
                    },
                    "enrollmentInfo": {
                        "count": 82,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "T-DM1",
                            "type": "EXPERIMENTAL",
                            "description": "T-DM1 will be administered every 3 weeks intravenously, with 21 consecutive days defined as a treatment.",
                            "interventionNames": [
                                "Drug: T-DM1"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "T-DM1",
                            "description": "T-DM1 is an antibody-drug conjugate; it is made up of an antibody (trastuzumab) linked to a cytotoxic drug, DM1 (chemotherapy). T-DM1 functions as a targeted cancer therapy because it targets HER2-positive breast cancer cells directly, limiting exposure of the rest of the body to chemotherapy.",
                            "armGroupLabels": [
                                "T-DM1"
                            ],
                            "otherNames": [
                                "Kadcyla"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "5-year invasive disease-free survival rate",
                            "description": "To evaluate invasive disease-free survival (IDFS) for patient receiving T-DM1",
                            "timeFrame": "5 years"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Recurrence-free survival",
                            "description": "To evaluate recurrence-free survival (RFS) for patient receiving T-DM1, defined as the time from study enrollment to disease recurrence and will not include death as an event.",
                            "timeFrame": "2 years"
                        },
                        {
                            "measure": "Overall Survival",
                            "description": "To evaluate overall survival (OS) for patient receiving T-DM1, defined as the time from study enrollment to death attributable to any cause (i.e. death from breast cancer, non-breast cancer cause, or from unknown cause).",
                            "timeFrame": "2 years"
                        },
                        {
                            "measure": "Site of first recurrence",
                            "description": "To evaluate site of first recurrence for patient receiving T-DM1, which will be tabulated as frequencies and relative frequencies.",
                            "timeFrame": "2 years"
                        },
                        {
                            "measure": "Incidence Rate of each Toxicity (Safety)",
                            "description": "To evaluate adverse events for patient receiving T-DM1, defined as adverse events of all grades utilizing CTCAE v4",
                            "timeFrame": "2 years"
                        },
                        {
                            "measure": "Incidence Rate of Cardiac-Related Adverse Events (left ventricular systolic dysfunction)",
                            "description": "To evaluate cardiac-related adverse events for patients receiving T-DM1, defined as incidence of symptomatic left ventricular systolic dysfunction",
                            "timeFrame": "2 years"
                        },
                        {
                            "measure": "Incidence Rate of Cardiac-Related Adverse Events (cardiac death)",
                            "description": "To evaluate cardiac-related adverse events for patients receiving T-DM1, defined as incidence of cardiac death",
                            "timeFrame": "2 years"
                        },
                        {
                            "measure": "Incidence Rate of Cardiac-Related Adverse Events (decreased ejection fraction)",
                            "description": "To evaluate cardiac-related adverse events for patients receiving T-DM1, defined as decrease in ejection fraction by at least 10 percentage points below baseline or to below 50%.",
                            "timeFrame": "2 years"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Participants must have histologically or cytologically confirmed HER2-positive disease by local pathology, defined as immunohistochemistry (IHC) 3+ or amplification by FISH (HER2/CEP17 ratio \u22652 or an average of \u22656 HER2 gene copies per nucleus) AND confirmed by Central Pathology Review (Dr. Deborah Dillon at Brigham and Women's Hospital, Boston, MA) prior to patient being registered to begin protocol therapy. See section 3.4. http://ascopubs.org/doi/full/10.1200/jco.2013.50.9984\n* NOTE: DCIS components should not be counted in the determination of HER2 status.\n* Age \u226560 years at the time of study registration (men and women eligible)\n* Participants must have histologically or cytologically confirmed Stage I-III breast cancer with the following criteria met:\n* If node-negative or if node status unknown (because it was not assessed), tumor must be \\>5 mm of any hormone receptor subtype (document ER/PR status: if some ER/PR staining is present, ER and PR negative are defined as being positive in \\<10% cells \\[per local pathology read\\]).\n* If node-positive (N1-N3), T1mi, T1a, T1b, T1c, T2, or T3 tumors are eligible (see below for further details on defining node-negative disease) Definition of node-negative disease (when node status known): If the patient has had a negative sentinel node biopsy and/or a negative axillary dissection, then the patient is determined to be node-negative. Axillary nodes with single cells or tumor clusters \u2264 0.2 mm by either H\\&E or IHC will be considered node-negative. Any axillary lymph node with tumor clusters between 0.02 and 0.2cm is considered a micrometastasis. Patients with a micrometastasis are eligible even if their tumor is \\</= 5mm. An axillary dissection is not required to be performed in patients with a positive sentinel node and management of the axilla will be left up to the treating provider. In cases where the specific pathologic size of lymph node involvement is subject to interpretation, the principal investigator will make the final determination as to eligibility. In these special situations, the investigator must document this approval in the patient medical record.\n* ER/PR determination assays performed by IHC methods according to the local institution standard protocol.\n* Standard chemotherapy/trastuzumab declined by patient OR patient is deemed by physician for any reason to not be a candidate for standard therapy (i.e. patient and/or provider choose not to pursue standard trastuzumab-based chemotherapy regimen because of concerns related to toxicity or provider/patient preference).\n* For patients with bilateral or multifocal/multicentric breast cancers, one of the following criteria must be met to enroll: (1) each cancer individually meets criteria for enrollment (only ONE tumor has to undergo central confirmation for HER2), (2) at least one tumor meets eligibility (per tumor size/nodes/subtype outlined above) and the other foci in the ipsilateral or contralateral breast are also HER2-positive but are too small for enrollment (e.g., a patient is eligible if a cancer is T2N0 and HER2-positive in one breast, but the contralateral breast has a T1a HER2+ cancer that isn't eligible on its own, (3) there is at least one qualifying tumor of \\>5mm but there are other small foci of disease that are too small to test for ER/PR/HER2 and are felt to be a part of the same tumor or similar tumor, OR (4) at least one tumor meets eligibility and the other foci in the ipsilateral or contralateral breast are HER2-negative and do not meet criteria for adjuvant chemotherapy per provider discretion (e.g. if a patient has a HER2-positive tumor meeting eligibility but also has a second, HER2-negative, small, node-negative, ER+, low grade cancer present, she is still eligible for enrollment). However, in the specific case that a second breast cancer is stage III and HER2-negative, that patient is excluded (because the second cancer is high-risk and likely will require non-HER2-directed therapy).\n* All tumor removed by either a modified radical mastectomy or a segmental mastectomy (lumpectomy).\n* NOTE: Management of axillary lymph nodes is up to the treating provider; however, all surgical margins should be clear of invasive cancer or DCIS (i.e., no tumor on ink). The local pathologist must document negative margins of resection in the pathology report. If all other margins are clear, a positive posterior (deep) margin is permitted, provided the surgeon documents that the excision was performed down to the pectoral fascia and all tumor has been removed. Likewise, if all other margins are clear, a positive anterior (superficial; abutting skin) margin is permitted provided the surgeon documents that all tumor has been removed.\n\n  -\u226490 days from the patient's most recent breast surgery for this breast cancer. Note: In cases where registration will occur \\>90 days from surgery but within an acceptable time frame, patient may be eligible for enrollment with approval from the PI, Rachel Freedman MD, MPH.\n* ECOG Performance Status (PS) 0-2. See Appendix F.\n* Baseline ejection fraction \u226550% by MUGA scan or echocardiogram performed \u226460 days prior to registration.\n* The following laboratory values obtained \u226414 days prior to registration:\n\n  * Absolute neutrophil count (ANC) \u22651500/mm3\n  * Platelet count \u2265100,000/mm3\n  * Hemoglobin \\>9.0 g/dL\n  * Total bilirubin \u22641.5 x upper limit of normal (ULN). If patient has known Gilbert's syndrome, the suggested threshold for treatment is a total bilirubin \u22642.0 x ULN, but will be left to the treating providers discretion.\n  * AST and ALT \u22642.5 x ULN, alkaline phosphatase \u22642.5 x ULN\n  * INR \\<1.5 x ULN for institution unless patient is on planned therapy with anticoagulants (i.e., warfarin) with higher target planned. In those cases, INR up to 3.5 is acceptable.\n  * PTT \\<1.5 x ULN for institution unless patient is on planned therapy with heparin or heparin-like products Note: In the case of longstanding ethnic neutropenia, patient may be eligible for enrollment with approval from the PI, Rachel Freedman MD, MPH.\n* Life expectancy \\>5 years per provider's assessment\n* Willing to employ adequate and appropriate birth control if applicable\n* NOTE: This study is for patients aged 60 and older, and most female patients will have entered menopause by this time; however patients should not become pregnant while on this study because T-DM1 can affect an unborn baby. Pre-menopausal women need to use birth control while on this study and women should not breastfeed a baby while on this study. Any man treated on this study will also need to use contraception if his partner is a premenopausal female. Patients should check with their health care provider about what kind of birth control methods to use and how long to use them.\n* Negative urine or serum pregnancy test done \u22647 days prior to registration, for women of childbearing potential only\n* NOTE: In the rare case that a woman enrolling on study is of childbearing potential, a pregnancy test is required prior to enrollment on study.\n* Able to provide informed written consent.\n* Willing to return to consenting institution for follow-up at 6 months\n* Willing to provide blood samples for mandatory correlative research purposes.\n* Ability to understand and the willingness to sign a written informed consent document\n\nExclusion Criteria:\n\n* Evidence of metastatic disease.\n* Patients will not require baseline staging PET or CT chest, abdomen, pelvis or bone scan to rule out metastatic disease prior to enrollment. Any staging scans will be ordered at the treating provider's discretion. If metastatic disease is found on any staging studies done, patients will not be eligible for enrollment.\n* Locally advanced tumors at diagnosis (T4), including tumors fixed to the chest wall, peau d'orange, skin ulcerations/nodules, or clinical inflammatory changes (diffuse brawny cutaneous induration with an erysipeloid).\n* Patients with stage III, HER2-negative cancer in the contralateral breast (see 3.1.6 above).\n* Positive Hepatitis B (Hepatitis B surface antigen and antibody) and/or Hepatitis C (Hepatitis C antibody test) as indicated by serologies conducted \u22643 months prior to registration if liver function tests are outside of the normal institutional range.\n\nNOTE: A hepatitis panel is required of all participants as part of screening. Patients with positive Hepatitis B or C serologies indicating active infection without known active disease must meet the eligibility requirements for ALT, AST, total bilirubin, INR, PTT, and alkaline phosphatase on at least two consecutive occasions, separated by at least 1 week. Patients with laboratory evidence of vaccination to Hepatitis B (e.g., positive antibodies) are eligible.\n\n* Active liver disease, for example, due to autoimmune hepatic disorder, or sclerosing cholangitis.\n* Significant, active cardiopulmonary dysfunction (i.e. uncontrolled heart issues)as indicated by MUGA or echocardiogram performed \u226460 days prior to registration and/or by presence of any of the following:\n\n  * History of NCI CTCAE (Version 4.0) Grade \u22653 symptomatic congestive heart failure (CHF) or NYHA criteria Class \u2265 II\n  * Angina pectoris requiring anti-anginal medication, serious cardiac arrhythmia not controlled by adequate medication, severe conduction abnormality, or clinically significant valvular disease\n  * High-risk uncontrolled arrhythmias (i.e., atrial tachycardia with a heart rate \\> 100/min at rest, significant ventricular arrhythmia \\[ventricular tachycardia\\], or higher-grade atrioventricular \\[AV\\]-block \\[second degree AV-block Type 2 \\[Mobitz 2\\] or third degree AV-block\\]); if adequately and safely treated, patient may be eligible.\n  * Significant symptoms (Grade \u2265 2) relating to left ventricular dysfunction, cardiac arrhythmia, or cardiac ischemia\n  * Myocardial infarction within 12 months prior to registration\n  * Uncontrolled hypertension (systolic blood pressure \\> 180 mmHg and/or diastolic blood pressure \\>100 mmHg)\n  * Evidence of transmural infarction on ECG\n  * Requirement for oxygen therapy\n* Co-morbid systemic illnesses or other severe concurrent disease which, in the judgment of the investigator, would make the patient inappropriate for entry into this study or interfere significantly with the proper assessment of safety and toxicity of the prescribed regimens.\n* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection or psychiatric illness/social situations that would limit compliance with study requirements.\n* Currently receiving any other investigational agent which would be considered as a treatment for the primary neoplasm.\n* Concurrent second malignancy or past malignancy with \\>30% estimated risk of relapse in next 5 years. EXCEPTIONS: Non-melanotic skin cancer or carcinoma-in-situ of the cervix in addition to smoldering pre-malignant or malignant conditions with minimized concern for clinical progression during treatment such as MGUS or CLL, based on treating provider's assessment. -NOTE: If there is a history or prior malignancy, patient must not be receiving active treatment for this malignancy cancer.\n* Any prior treatment with T-DM1 or any trastuzumab therapy.\n* Any neoadjuvant chemotherapy for this breast cancer.\n\n  -\\>90 days of tamoxifen therapy, or other hormonal therapy, for adjuvant therapy for this malignancy\n* NOTE: If the patient has received \\<90 days of such therapy but is still receiving it at the time of entry into the study, patient must temporarily stop the therapy prior to Cycle 1 Day 1. The therapy can re-start only after 6 weeks of T-DM1 have been administered (anytime after C3D1).\n* History of exposure at any time to the following cumulative doses of anthracyclines:\n\n  * Doxorubicin or liposomal doxorubicin \\>500mg/m2.\n  * Epirubicin \\>900mg/m2.\n  * Mitoxantrone \\>120 mg/m2.\n  * Another anthracycline, or more than one anthracycline used in a cumulative dose exceeding the equivalent of doxorubicin 500mg/m2.\n* History of intolerance (including Grade 3 or 4 infusion reactions) to murine proteins.\n* History of previous invasive breast cancer \u22645 years.\n* NOTE: History of DCIS, LCIS is allowed.",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "60 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Rachel Freedman, MD MPH",
                            "affiliation": "Dana-Farber Cancer Institute",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "City of Hope Comprehensive Cancer Center",
                            "city": "Duarte",
                            "state": "California",
                            "zip": "91010",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 34.13945,
                                "lon": -117.97729
                            }
                        },
                        {
                            "facility": "The Stamford Hospital",
                            "city": "Stamford",
                            "state": "Connecticut",
                            "zip": "06904",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.05343,
                                "lon": -73.53873
                            }
                        },
                        {
                            "facility": "Dana Farber Cancer Institute",
                            "city": "Boston",
                            "state": "Massachusetts",
                            "zip": "02215",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.35843,
                                "lon": -71.05977
                            }
                        },
                        {
                            "facility": "Massachusetts General Hospital",
                            "city": "Boston",
                            "state": "Massachusetts",
                            "zip": "02215",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.35843,
                                "lon": -71.05977
                            }
                        },
                        {
                            "facility": "Dana-Farber Cancer Institute at St. Elizabeth's Medical Center",
                            "city": "Brighton",
                            "state": "Massachusetts",
                            "zip": "02135",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.3501,
                                "lon": -71.15644
                            }
                        },
                        {
                            "facility": "Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center",
                            "city": "Milford",
                            "state": "Massachusetts",
                            "zip": "01757",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.13982,
                                "lon": -71.51617
                            }
                        },
                        {
                            "facility": "Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital",
                            "city": "South Weymouth",
                            "state": "Massachusetts",
                            "zip": "02190",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.1751,
                                "lon": -70.94949
                            }
                        },
                        {
                            "facility": "Mayo Clinic",
                            "city": "Rochester",
                            "state": "Minnesota",
                            "zip": "55905",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 44.02163,
                                "lon": -92.4699
                            }
                        },
                        {
                            "facility": "Dana-Farber/New Hampshire Oncology-Hematology",
                            "city": "Londonderry",
                            "state": "New Hampshire",
                            "zip": "03053",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 42.86509,
                                "lon": -71.37395
                            }
                        },
                        {
                            "facility": "Memorial Sloan Kettering Cancer Center",
                            "city": "New York",
                            "state": "New York",
                            "zip": "10065",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.71427,
                                "lon": -74.00597
                            }
                        },
                        {
                            "facility": "University of North Carolina",
                            "city": "Chapel Hill",
                            "state": "North Carolina",
                            "zip": "27599",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.9132,
                                "lon": -79.05584
                            }
                        },
                        {
                            "facility": "Rex Cancer Center",
                            "city": "Raleigh",
                            "state": "North Carolina",
                            "zip": "27607",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 35.7721,
                                "lon": -78.63861
                            }
                        },
                        {
                            "facility": "Lifespan Cancer Institute",
                            "city": "Providence",
                            "state": "Rhode Island",
                            "zip": "02903",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.82399,
                                "lon": -71.41283
                            }
                        },
                        {
                            "facility": "Sarah Cannon Research Institute",
                            "city": "Nashville",
                            "state": "Tennessee",
                            "zip": "37203",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.16589,
                                "lon": -86.78444
                            }
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D001943",
                            "term": "Breast Neoplasms"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D009371",
                            "term": "Neoplasms by Site"
                        },
                        {
                            "id": "D009369",
                            "term": "Neoplasms"
                        },
                        {
                            "id": "D001941",
                            "term": "Breast Diseases"
                        },
                        {
                            "id": "D012871",
                            "term": "Skin Diseases"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M5220",
                            "name": "Breast Neoplasms",
                            "asFound": "Breast Cancer",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M5218",
                            "name": "Breast Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M15674",
                            "name": "Skin Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T4025",
                            "name": "Myotonic Dystrophy Type 1",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC04",
                            "name": "Neoplasms"
                        },
                        {
                            "abbrev": "BC17",
                            "name": "Skin and Connective Tissue Diseases"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "Rare",
                            "name": "Rare Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D000080044",
                            "term": "Ado-Trastuzumab Emtansine"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D000074322",
                            "term": "Antineoplastic Agents, Immunological"
                        },
                        {
                            "id": "D000970",
                            "term": "Antineoplastic Agents"
                        },
                        {
                            "id": "D000922",
                            "term": "Immunotoxins"
                        },
                        {
                            "id": "D018796",
                            "term": "Immunoconjugates"
                        },
                        {
                            "id": "D007155",
                            "term": "Immunologic Factors"
                        },
                        {
                            "id": "D045505",
                            "term": "Physiological Effects of Drugs"
                        },
                        {
                            "id": "D050257",
                            "term": "Tubulin Modulators"
                        },
                        {
                            "id": "D050256",
                            "term": "Antimitotic Agents"
                        },
                        {
                            "id": "D050258",
                            "term": "Mitosis Modulators"
                        },
                        {
                            "id": "D045504",
                            "term": "Molecular Mechanisms of Pharmacological Action"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M4225",
                            "name": "Antibodies",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M325",
                            "name": "Trastuzumab",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10184",
                            "name": "Immunoglobulins",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M11900",
                            "name": "Mitogens",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M2102",
                            "name": "Ado-Trastuzumab Emtansine",
                            "asFound": "Xenograft",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M3595",
                            "name": "Adenosine",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M1346",
                            "name": "Antineoplastic Agents, Immunological",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M4241",
                            "name": "Immunotoxins",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M20855",
                            "name": "Immunoconjugates",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10201",
                            "name": "Immunologic Factors",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M26197",
                            "name": "Tubulin Modulators",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M26196",
                            "name": "Antimitotic Agents",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "ANeo",
                            "name": "Antineoplastic Agents"
                        },
                        {
                            "abbrev": "AnArAg",
                            "name": "Anti-Arrhythmia Agents"
                        },
                        {
                            "abbrev": "VaDiAg",
                            "name": "Vasodilator Agents"
                        },
                        {
                            "abbrev": "Analg",
                            "name": "Analgesics"
                        }
                    ]
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT03690206",
                    "orgStudyIdInfo": {
                        "id": "ZP1848-17111"
                    },
                    "organization": {
                        "fullName": "Zealand Pharma",
                        "class": "INDUSTRY"
                    },
                    "briefTitle": "Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS)",
                    "officialTitle": "A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Glepaglutide in Patients With Short Bowel Syndrome (SBS)",
                    "acronym": "EASE SBS 1"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2018-10-04",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2022-07-26",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2022-07-26",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2018-09-17",
                    "studyFirstSubmitQcDate": "2018-09-27",
                    "studyFirstPostDateStruct": {
                        "date": "2018-10-01",
                        "type": "ACTUAL"
                    },
                    "resultsFirstSubmitDate": "2024-05-30",
                    "resultsFirstSubmitQcDate": "2024-10-18",
                    "resultsFirstPostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    },
                    "dispFirstSubmitDate": "2023-05-23",
                    "dispFirstPostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-18",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Zealand Pharma",
                        "class": "INDUSTRY"
                    }
                },
                "oversightModule": {
                    "oversightHasDmc": false,
                    "isFdaRegulatedDrug": true,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "The primary objective of the trial is to confirm the efficacy of glepaglutide in reducing parenteral support volume in patients with short bowel syndrome.\n\nGlepaglutide is the International Nonproprietary Name and USAN for ZP1848.",
                    "detailedDescription": "A Phase 3, international, multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of glepaglutide subcutaneous (SC) injections in patients with short bowel syndrome (SBS)."
                },
                "conditionsModule": {
                    "conditions": [
                        "Short Bowel Syndrome"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "PHASE3"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "QUADRUPLE",
                            "whoMasked": [
                                "PARTICIPANT",
                                "CARE_PROVIDER",
                                "INVESTIGATOR",
                                "OUTCOMES_ASSESSOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 106,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Glepaglutide SC injections twice weekly",
                            "type": "EXPERIMENTAL",
                            "description": "Intervention: Glepaglutide",
                            "interventionNames": [
                                "Drug: glepaglutide"
                            ]
                        },
                        {
                            "label": "Glepaglutide SC injections once weekly and placebo once weekly",
                            "type": "EXPERIMENTAL",
                            "description": "Intervention: Glepaglutide",
                            "interventionNames": [
                                "Drug: glepaglutide",
                                "Drug: Placebo"
                            ]
                        },
                        {
                            "label": "Placebo SC injections twice weekly",
                            "type": "PLACEBO_COMPARATOR",
                            "description": "Intervention: Placebo",
                            "interventionNames": [
                                "Drug: Placebo"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "DRUG",
                            "name": "glepaglutide",
                            "description": "Glucagon-Like Peptide-2 (GLP-2) analog",
                            "armGroupLabels": [
                                "Glepaglutide SC injections once weekly and placebo once weekly",
                                "Glepaglutide SC injections twice weekly"
                            ],
                            "otherNames": [
                                "ZP1848"
                            ]
                        },
                        {
                            "type": "DRUG",
                            "name": "Placebo",
                            "description": "Placebo for glepaglutide",
                            "armGroupLabels": [
                                "Glepaglutide SC injections once weekly and placebo once weekly",
                                "Placebo SC injections twice weekly"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Change in Weekly Parenteral Support (PS) Volume",
                            "description": "Change in weekly PS volume from baseline to Week 24. Baseline actual weekly PS volume was defined as the actual PS volume derived from a valid 7-day period prior to visit 1 (Day 1), i.e. during the stabilization phase. The actual weekly PS volume at Weeks 1, 2, 4, 8, 12, 16, 20, and 24 was derived as the actual weekly PS volume received during the valid 7-day period prior to the visit. The source for the derivation was the PS volumes recorded by the patients in the eDiary.",
                            "timeFrame": "24 weeks"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Clinical Response in PS Volume",
                            "description": "Clinical response, defined as at least 20% reduction in actual weekly PS volume from baseline to both Weeks 20 and 24.",
                            "timeFrame": "20 and 24 weeks"
                        },
                        {
                            "measure": "Days Off PS",
                            "description": "Achieving 1 or more days per week off PS",
                            "timeFrame": "24 weeks"
                        },
                        {
                            "measure": "Clinical Response in PS Volume",
                            "description": "Reduction of at least 20 percent in PS volume from baseline to both 12 and 24 weeks.",
                            "timeFrame": "12 and 24 weeks"
                        },
                        {
                            "measure": "Weaned Off PS",
                            "description": "Reduction in weekly PS volume of 100 percent (weaned off)",
                            "timeFrame": "24 weeks"
                        },
                        {
                            "measure": "Energy Content",
                            "description": "Change in weekly energy content of PS from baseline",
                            "timeFrame": "24 weeks"
                        },
                        {
                            "measure": "Days on PS",
                            "description": "Change in number of days on PS per week from baseline",
                            "timeFrame": "24 weeks"
                        },
                        {
                            "measure": "Change in PS Volume Per Week",
                            "description": "Achieving reduction of at least 40 percent in PS volume from baseline to both 20 and 24 weeks",
                            "timeFrame": "20 and 24 weeks"
                        },
                        {
                            "measure": "Patient Global Impression of Change Scale (PGIC)",
                            "description": "Patient Global Impression of Change scale (PGIC) improvement at Weeks 4, 12, 20, and 24 PGIC improvement was defined as responding \"Very Much Improved\" or \"Much Improved\" on a 7-point Likert Scale. Improvement between each glepaglutide treatment regimen compared to placebo was tested by week, using the CMH test adjusted for the stratification factor. Improvement between each glepaglutide treatment regimen versus placebo was tested using collapsed categories of Improvement, No Change, and Worsening, where Improvement is defined as a response of \"Very Much Improved\" or \"Much Improved\" or \"Minimally Improved\", and No Change is defined as the response of \"No Change\", and Worsening is defined as a response of \"Minimally Worse\" or \"Much Worse\" or \"Very Much Worse\". Improvement using collapsed categories between each glepaglutide treatment regimen compared to placebo was tested by week using a Mantel-Haenszel chi-squared test for ordered categories.",
                            "timeFrame": "24 weeks"
                        },
                        {
                            "measure": "Safety - Adverse Events",
                            "description": "Incidence and type of Adverse Events over an average of 28 weeks (24 weeks treatment + 4 weeks follow up)",
                            "timeFrame": "28 weeks"
                        },
                        {
                            "measure": "Number of Patients With Clinically Significant Changes in 12-Lead Electrocardiogram (ECG)",
                            "description": "Number of patients with clinically significant changes in ECG will be reported. Monitored ECG parameters included heart rate (beats/min), PR interval (ms), PR interval Aggregate (ms), QRS duration aggregate (ms), QT interval aggregate (ms), QTcF interval aggregate (ms), and RR interval (ms), as well as the overall interpretation of each subject's ECG recorded as Normal, Abnormal Not Clinically Significant, or Abnormal Clinically Significant.",
                            "timeFrame": "28 weeks"
                        },
                        {
                            "measure": "Safety - Changes in Blood Pressure From Baseline",
                            "description": "Changes in blood pressure are reported at Week 1, Week 2, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 24 The data collected data are of seated diastolic and systolic blood pressure (mmHg). During treatment phase visits, vital signs were collected before investigational product injection.",
                            "timeFrame": "Week 1, Week 2, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 24"
                        },
                        {
                            "measure": "Safety - Changes in Body Temperature From Baseline",
                            "description": "Changes in body temperature are reported The body temperature (\u00baC or \u00baF) was measured according to the site's usual procedure. During treatment phase visits, vital signs were collected before investigational product injection.",
                            "timeFrame": "28 weeks"
                        },
                        {
                            "measure": "Immunogenicity - Occurrence of Anti-drug Antibodies",
                            "description": "Occurrence of antibodies against glepaglutide The occurrence of glepaglutide-binding antibodies (ADA), M2 binding antibodies (M2 BAb), glepaglutide neutralizing antibodies (NAb) and GLP-2 cross-reacting antibodies (GLP-2 CR) was tested.",
                            "timeFrame": "28 weeks"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Informed consent obtained before any trial-related activity.\n* Diagnosis of SBS defined as remaining small bowel in continuity of estimated less than 200 cm and considered stable with regard to PS need. No restorative surgery planned in the trial period.\n* Requiring PS at least 3 days per week and maintains a stable PS volume for at least 2 weeks.\n* In case of remnant colon: documented colonoscopy which does not give rise to any safety concerns.\n\nExclusion Criteria:\n\n* More than 2 SBS-related or PS-related hospitalizations within 6 months prior to Screening. No SBS-related hospitalizations within 30 days prior to randomization.\n* Poorly controlled inflammatory bowel disease that is moderately or severely active or fistula interfering with measurements or examinations required in the trial.\n* Bowel obstruction.\n* Known radiation enteritis or significant villous atrophy.\n* Cardiac disease defined as: decompensated heart failure (New York Heart Association \\[NYHA\\] Class III-IV), unstable angina pectoris, and/or myocardial infarction within the last 6 months prior to Screening.\n* Clinically significant abnormal ECG.\n* Repeated systolic blood pressure measurements \\> 180 mm Hg.\n* Human immunodeficiency virus positive, acute liver disease, or unstable chronic liver disease.\n* Any history of colon cancer. History of any other cancers unless disease-free state for at least 5 years.\n* Estimated creatinine clearance \\< 30 mL/min.\n* Severe hepatic impairment.\n* Use of GLP-1, GLP-2, human growth hormone, somatostatin, or analogs thereof, within 3 months prior to Screening.\n* Use of dipeptidyl peptidase (DPP)-4 inhibitors within 3 months prior to Screening.\n* Unstable systemic immunosuppressive therapy within 3 months prior to Screening.\n* Unstable biological therapy within 6 months prior to Screening.\n* Females of childbearing potential, who are pregnant, breast-feeding, intend to become pregnant or are not using highly effective contraceptive methods.\n* Previous exposure to glepaglutide.\n* Current, or within 30 days prior to Screening, participation in another interventional clinical trial that includes administration of an active compound.\n* Any condition or disease or circumstance that in the Investigator's opinion would put the patient at any undue risk, prevent completion of the trial, or interfere with the analysis of the trial results.",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "maximumAge": "90 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Study Director",
                            "affiliation": "Zealand Pharma",
                            "role": "STUDY_DIRECTOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Georgetown University Medical Center",
                            "city": "Washington",
                            "state": "District of Columbia",
                            "zip": "20007",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 38.89511,
                                "lon": -77.03637
                            }
                        },
                        {
                            "facility": "University of Chicago Children's Hospital",
                            "city": "Chicago",
                            "state": "Illinois",
                            "zip": "60637",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.85003,
                                "lon": -87.65005
                            }
                        },
                        {
                            "facility": "Mayo Clinic College of Medicine",
                            "city": "Rochester",
                            "state": "Minnesota",
                            "zip": "55905",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 44.02163,
                                "lon": -92.4699
                            }
                        },
                        {
                            "facility": "University of Nebraska Medical Center",
                            "city": "Omaha",
                            "state": "Nebraska",
                            "zip": "68198-3285",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.25626,
                                "lon": -95.94043
                            }
                        },
                        {
                            "facility": "Mount Sinai Hospital",
                            "city": "New York",
                            "state": "New York",
                            "zip": "10029",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 40.71427,
                                "lon": -74.00597
                            }
                        },
                        {
                            "facility": "Cleveland Clinic",
                            "city": "Cleveland",
                            "state": "Ohio",
                            "zip": "44195",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 41.4995,
                                "lon": -81.69541
                            }
                        },
                        {
                            "facility": "Vanderbilt University Medical Center, Nashville",
                            "city": "Nashville",
                            "state": "Tennessee",
                            "zip": "68198-3285",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 36.16589,
                                "lon": -86.78444
                            }
                        },
                        {
                            "facility": "UZ Leuven",
                            "city": "Leuven",
                            "country": "Belgium",
                            "geoPoint": {
                                "lat": 50.87959,
                                "lon": 4.70093
                            }
                        },
                        {
                            "facility": "The Royal Alexandra Hospital",
                            "city": "Edmonton",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 53.55014,
                                "lon": -113.46871
                            }
                        },
                        {
                            "facility": "Western University",
                            "city": "London",
                            "zip": "N6A 4V2",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 42.98339,
                                "lon": -81.23304
                            }
                        },
                        {
                            "facility": "University Health Network - Toronto General Hospital",
                            "city": "Toronto",
                            "country": "Canada",
                            "geoPoint": {
                                "lat": 43.70011,
                                "lon": -79.4163
                            }
                        },
                        {
                            "facility": "Aalborg University Hospital",
                            "city": "Aalborg",
                            "zip": "9000",
                            "country": "Denmark",
                            "geoPoint": {
                                "lat": 57.048,
                                "lon": 9.9187
                            }
                        },
                        {
                            "facility": "Rigshospitalet",
                            "city": "Copenhagen",
                            "country": "Denmark",
                            "geoPoint": {
                                "lat": 55.67594,
                                "lon": 12.56553
                            }
                        },
                        {
                            "facility": "H\u00f4pital Beaujon",
                            "city": "Clichy",
                            "country": "France",
                            "geoPoint": {
                                "lat": 48.90018,
                                "lon": 2.30952
                            }
                        },
                        {
                            "facility": "Centre Hospitalier Lyon-Sud",
                            "city": "Pierre-B\u00e9nite",
                            "country": "France",
                            "geoPoint": {
                                "lat": 45.7009,
                                "lon": 4.82511
                            }
                        },
                        {
                            "facility": "Charit\u00e9 - Universit\u00e4tsmedizin Berlin",
                            "city": "Berlin",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 52.52437,
                                "lon": 13.41053
                            }
                        },
                        {
                            "facility": "Universit\u00e4tsklinikum Bonn",
                            "city": "Bonn",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.73438,
                                "lon": 7.09549
                            }
                        },
                        {
                            "facility": "Universit\u00e4tsklinikum Frankfurt - Med. Klinik I",
                            "city": "Frankfurt",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 50.11552,
                                "lon": 8.68417
                            }
                        },
                        {
                            "facility": "Asklepios Kliniken Hamburg GmbH",
                            "city": "Hamburg",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 53.57532,
                                "lon": 10.01534
                            }
                        },
                        {
                            "facility": "Universit\u00e4tsmedizin Rostock",
                            "city": "Rostock",
                            "country": "Germany",
                            "geoPoint": {
                                "lat": 54.0887,
                                "lon": 12.14049
                            }
                        },
                        {
                            "facility": "UMC Radboud Nijmegen",
                            "city": "Nijmegen",
                            "country": "Netherlands",
                            "geoPoint": {
                                "lat": 51.8425,
                                "lon": 5.85278
                            }
                        },
                        {
                            "facility": "Solumed",
                            "city": "Pozna\u0144",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 52.40692,
                                "lon": 16.92993
                            }
                        },
                        {
                            "facility": "Szpital Skawina sp. z o.o. im. Stanley Dudricka",
                            "city": "Skawina",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 49.97524,
                                "lon": 19.82869
                            }
                        },
                        {
                            "facility": "Wojewodzki Specjalistyczny Szpital im. M. Pirogowa w Lodzi",
                            "city": "\u0141\u00f3d\u017a",
                            "country": "Poland",
                            "geoPoint": {
                                "lat": 51.75,
                                "lon": 19.46667
                            }
                        },
                        {
                            "facility": "St Mark's Hospital",
                            "city": "Harrow",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 51.57142,
                                "lon": -0.33371
                            }
                        },
                        {
                            "facility": "UCLH Foundation NHS Trust",
                            "city": "London",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 51.50853,
                                "lon": -0.12574
                            }
                        },
                        {
                            "facility": "Salford Royal NHS Foundation Trust",
                            "city": "Manchester",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 53.48095,
                                "lon": -2.23743
                            }
                        },
                        {
                            "facility": "University of East Anglia",
                            "city": "Norwich",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 52.62783,
                                "lon": 1.29834
                            }
                        },
                        {
                            "facility": "University Hospital Southampton NHS Foundation Trust",
                            "city": "Southampton",
                            "country": "United Kingdom",
                            "geoPoint": {
                                "lat": 50.90395,
                                "lon": -1.40428
                            }
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "UNDECIDED"
                }
            },
            "resultsSection": {
                "participantFlowModule": {
                    "preAssignmentDetails": "Patients were diagnosed with SBS and required PS at least 3 days/week. They were willing to adhere to an individual pre-defined drinking menu during 48 h measurement periods and maintain a stable weight.\n\nThe drinking menu and the PS volume and content were adjusted during an optimization phase following by a stabilization phase.",
                    "recruitmentDetails": "This trial was conducted in (number of sites that randomized patients in parenthesis) Belgium (1), Denmark (2), France (2), Germany (5), the Netherlands (1), Poland (3), Canada (3), the US (7), and the UK (5).",
                    "groups": [
                        {
                            "id": "FG000",
                            "title": "Glepaglutide SC Injections Twice Weekly",
                            "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                        },
                        {
                            "id": "FG001",
                            "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                            "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide"
                        },
                        {
                            "id": "FG002",
                            "title": "Placebo SC Injections Twice Weekly",
                            "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide"
                        }
                    ],
                    "periods": [
                        {
                            "title": "Overall Study",
                            "milestones": [
                                {
                                    "type": "STARTED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "35"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "35"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "36"
                                        }
                                    ]
                                },
                                {
                                    "type": "COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "31"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "35"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "36"
                                        }
                                    ]
                                },
                                {
                                    "type": "NOT COMPLETED",
                                    "achievements": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "4"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "0"
                                        }
                                    ]
                                }
                            ],
                            "dropWithdraws": [
                                {
                                    "type": "Withdrawal by Subject",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "0"
                                        }
                                    ]
                                },
                                {
                                    "type": "ICF withdrawal",
                                    "reasons": [
                                        {
                                            "groupId": "FG000",
                                            "numSubjects": "2"
                                        },
                                        {
                                            "groupId": "FG001",
                                            "numSubjects": "0"
                                        },
                                        {
                                            "groupId": "FG002",
                                            "numSubjects": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "baselineCharacteristicsModule": {
                    "groups": [
                        {
                            "id": "BG000",
                            "title": "Glepaglutide SC Injections Twice Weekly",
                            "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                        },
                        {
                            "id": "BG001",
                            "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                            "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide"
                        },
                        {
                            "id": "BG002",
                            "title": "Placebo SC Injections Twice Weekly",
                            "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide"
                        },
                        {
                            "id": "BG003",
                            "title": "Total",
                            "description": "Total of all reporting groups"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "BG000",
                                    "value": "35"
                                },
                                {
                                    "groupId": "BG001",
                                    "value": "35"
                                },
                                {
                                    "groupId": "BG002",
                                    "value": "36"
                                },
                                {
                                    "groupId": "BG003",
                                    "value": "106"
                                }
                            ]
                        }
                    ],
                    "measures": [
                        {
                            "title": "Age, Categorical",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "<=18 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Between 18 and 65 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "23"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "28"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "81"
                                                }
                                            ]
                                        },
                                        {
                                            "title": ">=65 years",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "12"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "6"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "25"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Age, Continuous",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "years",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "56.9",
                                                    "spread": "13.4"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "54.0",
                                                    "spread": "12.0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "55.0",
                                                    "spread": "11.8"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "55.0",
                                                    "spread": "12.4"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Sex: Female, Male",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Female",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "19"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "18"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "20"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "57"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Male",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "16"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "17"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "16"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "49"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Ethnicity (NIH/OMB)",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "Hispanic or Latino",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "1"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Not Hispanic or Latino",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "33"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "32"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "95"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Unknown or Not Reported",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "10"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Race (NIH/OMB)",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "title": "American Indian or Alaska Native",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Asian",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "1"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Native Hawaiian or Other Pacific Islander",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Black or African American",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "3"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "White",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "28"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "31"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "89"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "More than one race",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "0"
                                                }
                                            ]
                                        },
                                        {
                                            "title": "Unknown or Not Reported",
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "13"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Region of Enrollment",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "participants",
                            "classes": [
                                {
                                    "title": "Canada",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "4"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Netherlands",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "4"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Belgium",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "10"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "United States",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "13"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "6"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "23"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Denmark",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "8"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Poland",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "8"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "12"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "27"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "United Kingdom",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "9"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "France",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "9"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Germany",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "12"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "BMI",
                            "paramType": "MEAN",
                            "dispersionType": "STANDARD_DEVIATION",
                            "unitOfMeasure": "kg/m^2",
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "BG000",
                                                    "value": "23.57",
                                                    "spread": "3.35"
                                                },
                                                {
                                                    "groupId": "BG001",
                                                    "value": "22.72",
                                                    "spread": "3.21"
                                                },
                                                {
                                                    "groupId": "BG002",
                                                    "value": "23.54",
                                                    "spread": "3.57"
                                                },
                                                {
                                                    "groupId": "BG003",
                                                    "value": "23.28",
                                                    "spread": "3.37"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "outcomeMeasuresModule": {
                    "outcomeMeasures": [
                        {
                            "type": "PRIMARY",
                            "title": "Change in Weekly Parenteral Support (PS) Volume",
                            "description": "Change in weekly PS volume from baseline to Week 24. Baseline actual weekly PS volume was defined as the actual PS volume derived from a valid 7-day period prior to visit 1 (Day 1), i.e. during the stabilization phase. The actual weekly PS volume at Weeks 1, 2, 4, 8, 12, 16, 20, and 24 was derived as the actual weekly PS volume received during the valid 7-day period prior to the visit. The source for the derivation was the PS volumes recorded by the patients in the eDiary.",
                            "populationDescription": "The Full Analysis Set (FAS) consisted of all randomized patients who received at least one dose of trial drug (glepaglutide or placebo). All efficacy analyses were based on the FAS. Patients were included in the analyses as randomized.",
                            "reportingStatus": "POSTED",
                            "paramType": "LEAST_SQUARES_MEAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "L/week",
                            "timeFrame": "24 weeks",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Glepaglutide SC Injections Twice Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Placebo SC Injections Twice Weekly",
                                    "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "36"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-5.13",
                                                    "lowerLimit": "-6.24",
                                                    "upperLimit": "-4.02"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-3.76",
                                                    "lowerLimit": "-4.96",
                                                    "upperLimit": "-2.56"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-2.85",
                                                    "lowerLimit": "-3.93",
                                                    "upperLimit": "-1.77"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG002"
                                    ],
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.0039",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "paramType": "Difference to Placebo",
                                    "paramValue": "-2.28",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-3.83",
                                    "ciUpperLimit": "-0.73"
                                },
                                {
                                    "groupIds": [
                                        "OG001",
                                        "OG002"
                                    ],
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.2700",
                                    "statisticalMethod": "Mixed Models Analysis",
                                    "paramType": "Difference to Placebo",
                                    "paramValue": "-0.91",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-2.52",
                                    "ciUpperLimit": "0.71"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Clinical Response in PS Volume",
                            "description": "Clinical response, defined as at least 20% reduction in actual weekly PS volume from baseline to both Weeks 20 and 24.",
                            "reportingStatus": "POSTED",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "timeFrame": "20 and 24 weeks",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Glepaglutide SC Injections Twice Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Placebo SC Injections Twice Weekly",
                                    "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "36"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "23"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "16"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "14"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG002"
                                    ],
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.0243",
                                    "statisticalMethod": "Cochran-Mantel-Haenszel",
                                    "paramType": "Difference to Placebo",
                                    "paramValue": "26.6",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "4.3",
                                    "ciUpperLimit": "48.9"
                                },
                                {
                                    "groupIds": [
                                        "OG001",
                                        "OG002"
                                    ],
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.6255",
                                    "statisticalMethod": "Cochran-Mantel-Haenszel",
                                    "paramType": "Difference to Placebo",
                                    "paramValue": "5.5",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-16.2",
                                    "ciUpperLimit": "27.1"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Days Off PS",
                            "description": "Achieving 1 or more days per week off PS",
                            "reportingStatus": "POSTED",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "timeFrame": "24 weeks",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Glepaglutide SC Injections Twice Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Placebo SC Injections Twice Weekly",
                                    "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "36"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "18"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "12"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "7"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG002"
                                    ],
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.0043",
                                    "statisticalMethod": "Cochran-Mantel-Haenszel",
                                    "paramType": "Difference to Placebo",
                                    "paramValue": "31.7",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "11.4",
                                    "ciUpperLimit": "51.9"
                                },
                                {
                                    "groupIds": [
                                        "OG001",
                                        "OG002"
                                    ],
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.1675",
                                    "statisticalMethod": "Cochran-Mantel-Haenszel",
                                    "paramType": "Difference to Placebo",
                                    "paramValue": "13.3",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "-5.4",
                                    "ciUpperLimit": "32.0"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Clinical Response in PS Volume",
                            "description": "Reduction of at least 20 percent in PS volume from baseline to both 12 and 24 weeks.",
                            "reportingStatus": "POSTED",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "timeFrame": "12 and 24 weeks",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Glepaglutide SC Injections Twice Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Placebo SC Injections Twice Weekly",
                                    "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "36"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "19"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "15"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "13"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Weaned Off PS",
                            "description": "Reduction in weekly PS volume of 100 percent (weaned off)",
                            "reportingStatus": "POSTED",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "timeFrame": "24 weeks",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Glepaglutide SC Injections Twice Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Placebo SC Injections Twice Weekly",
                                    "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "36"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "5"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ],
                            "analyses": [
                                {
                                    "groupIds": [
                                        "OG000",
                                        "OG002"
                                    ],
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.0160",
                                    "statisticalMethod": "Cochran-Mantel-Haenszel",
                                    "paramType": "Difference to Placebo",
                                    "paramValue": "14.1",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "2.5",
                                    "ciUpperLimit": "25.6"
                                },
                                {
                                    "groupIds": [
                                        "OG001",
                                        "OG002"
                                    ],
                                    "nonInferiorityType": "SUPERIORITY",
                                    "pValue": "0.0424",
                                    "statisticalMethod": "Cochran-Mantel-Haenszel",
                                    "paramType": "Difference to Placebo",
                                    "paramValue": "11.2",
                                    "ciPctValue": "95",
                                    "ciNumSides": "TWO_SIDED",
                                    "ciLowerLimit": "0.7",
                                    "ciUpperLimit": "21.6"
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Energy Content",
                            "description": "Change in weekly energy content of PS from baseline",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "Full Range",
                            "unitOfMeasure": "kJ/week",
                            "timeFrame": "24 weeks",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Glepaglutide SC Injections Twice Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Placebo SC Injections Twice Weekly",
                                    "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "26"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "28"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "27"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-7360.6",
                                                    "lowerLimit": "-48521",
                                                    "upperLimit": "130351"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-3085.9",
                                                    "lowerLimit": "-56550",
                                                    "upperLimit": "1423"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-734.2",
                                                    "lowerLimit": "-46307",
                                                    "upperLimit": "1670"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Days on PS",
                            "description": "Change in number of days on PS per week from baseline",
                            "reportingStatus": "POSTED",
                            "paramType": "MEDIAN",
                            "dispersionType": "Full Range",
                            "unitOfMeasure": "days/week",
                            "timeFrame": "24 weeks",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Glepaglutide SC Injections Twice Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Placebo SC Injections Twice Weekly",
                                    "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "31"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "36"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-1.00",
                                                    "lowerLimit": "-5.0",
                                                    "upperLimit": "0.0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.00",
                                                    "lowerLimit": "-7.0",
                                                    "upperLimit": "1.0"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0.00",
                                                    "lowerLimit": "-4.0",
                                                    "upperLimit": "0.0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Change in PS Volume Per Week",
                            "description": "Achieving reduction of at least 40 percent in PS volume from baseline to both 20 and 24 weeks",
                            "reportingStatus": "POSTED",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "timeFrame": "20 and 24 weeks",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Glepaglutide SC Injections Twice Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Placebo SC Injections Twice Weekly",
                                    "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "36"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "15"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "10"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "8"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Patient Global Impression of Change Scale (PGIC)",
                            "description": "Patient Global Impression of Change scale (PGIC) improvement at Weeks 4, 12, 20, and 24 PGIC improvement was defined as responding \"Very Much Improved\" or \"Much Improved\" on a 7-point Likert Scale. Improvement between each glepaglutide treatment regimen compared to placebo was tested by week, using the CMH test adjusted for the stratification factor. Improvement between each glepaglutide treatment regimen versus placebo was tested using collapsed categories of Improvement, No Change, and Worsening, where Improvement is defined as a response of \"Very Much Improved\" or \"Much Improved\" or \"Minimally Improved\", and No Change is defined as the response of \"No Change\", and Worsening is defined as a response of \"Minimally Worse\" or \"Much Worse\" or \"Very Much Worse\". Improvement using collapsed categories between each glepaglutide treatment regimen compared to placebo was tested by week using a Mantel-Haenszel chi-squared test for ordered categories.",
                            "reportingStatus": "POSTED",
                            "paramType": "NUMBER",
                            "unitOfMeasure": "participants",
                            "timeFrame": "24 weeks",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Glepaglutide SC Injections Twice Weekly",
                                    "description": "Intervention: Glepaglutide glepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                                    "description": "Intervention: Glepaglutide glepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog Placebo: Placebo for glepaglutide"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Placebo SC Injections Twice Weekly",
                                    "description": "Intervention: Placebo Placebo: Placebo for glepaglutide"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "36"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "PGIC improved",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "22"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "27"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "13"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "PGIC much/very much improved",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "17"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "11"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "2"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Safety - Adverse Events",
                            "description": "Incidence and type of Adverse Events over an average of 28 weeks (24 weeks treatment + 4 weeks follow up)",
                            "reportingStatus": "POSTED",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "timeFrame": "28 weeks",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Glepaglutide SC Injections Twice Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Placebo SC Injections Twice Weekly",
                                    "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "36"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "All AEs",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "33"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "33"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "26"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Serious adverse events",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "9"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "9"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "7"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "AE Severity: Severe",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "10"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "4"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "2"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "AE Severity: Moderate",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "15"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "17"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "14"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "AE Severity: Mild",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "28"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "31"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "23"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Relationship: Related",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "27"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "26"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "13"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Relationship: Unlikely related",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "18"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "16"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "9"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Relationship: Not related",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "26"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "23"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "20"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "AEs leading to trial withdrarwal",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "AEs with action taken drug withdrawn",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "AEs with action taken drug interrupted",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "3"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "3"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Outcome: Recovered/resolved",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "32"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "24"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Outcome: Recovering/resolving",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "7"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "9"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "5"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Outcome: Recovered/resolved with sequelae",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Outcome: Not recovered/not resolved",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "16"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "11"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "9"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Outcome: Fatal",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Outcome: Unknown",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "1"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Outcome: MIssing",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Number of Patients With Clinically Significant Changes in 12-Lead Electrocardiogram (ECG)",
                            "description": "Number of patients with clinically significant changes in ECG will be reported. Monitored ECG parameters included heart rate (beats/min), PR interval (ms), PR interval Aggregate (ms), QRS duration aggregate (ms), QT interval aggregate (ms), QTcF interval aggregate (ms), and RR interval (ms), as well as the overall interpretation of each subject's ECG recorded as Normal, Abnormal Not Clinically Significant, or Abnormal Clinically Significant.",
                            "reportingStatus": "POSTED",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "timeFrame": "28 weeks",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Glepaglutide SC Injections Twice Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Placebo SC Injections Twice Weekly",
                                    "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "36"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Safety - Changes in Blood Pressure From Baseline",
                            "description": "Changes in blood pressure are reported at Week 1, Week 2, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 24 The data collected data are of seated diastolic and systolic blood pressure (mmHg). During treatment phase visits, vital signs were collected before investigational product injection.",
                            "populationDescription": "At certain visits those data are missing for some patients.",
                            "reportingStatus": "POSTED",
                            "paramType": "LEAST_SQUARES_MEAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "mmHg",
                            "timeFrame": "Week 1, Week 2, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 24",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Glepaglutide SC Injections Twice Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Placebo SC Injections Twice Weekly",
                                    "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "36"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "Week 1 Systolic blood pressure",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "33"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "35"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-2.8",
                                                    "lowerLimit": "-7.6",
                                                    "upperLimit": "2.0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.3",
                                                    "lowerLimit": "-4.1",
                                                    "upperLimit": "4.7"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-4.5",
                                                    "lowerLimit": "-8.2",
                                                    "upperLimit": "-0.7"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 2 Systolic blood pressure",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "34"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "35"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "1.0",
                                                    "lowerLimit": "-3.2",
                                                    "upperLimit": "5.1"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.1",
                                                    "lowerLimit": "-4.6",
                                                    "upperLimit": "4.4"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-2.7",
                                                    "lowerLimit": "-6.4",
                                                    "upperLimit": "1.0"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 4 Systolic blood pressure",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "35"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "29"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "33"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-1.7",
                                                    "lowerLimit": "-6.5",
                                                    "upperLimit": "3.1"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.2",
                                                    "lowerLimit": "-3.9",
                                                    "upperLimit": "3.4"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-0.3",
                                                    "lowerLimit": "-4.6",
                                                    "upperLimit": "3.9"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 8 Systolic blood pressure",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "33"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "29"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "33"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.3",
                                                    "lowerLimit": "-5.4",
                                                    "upperLimit": "6.0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-1.5",
                                                    "lowerLimit": "-5.9",
                                                    "upperLimit": "2.9"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-2.5",
                                                    "lowerLimit": "-6.9",
                                                    "upperLimit": "1.8"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 12 Systolic blood pressure",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "32"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "29"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "34"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-4.4",
                                                    "lowerLimit": "-9.6",
                                                    "upperLimit": "0.8"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "3.3",
                                                    "lowerLimit": "-1.0",
                                                    "upperLimit": "7.6"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-0.4",
                                                    "lowerLimit": "-5.0",
                                                    "upperLimit": "4.1"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 16 Systolic blood pressure",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "29"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "32"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "33"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.1",
                                                    "lowerLimit": "-5.6",
                                                    "upperLimit": "5.8"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.4",
                                                    "lowerLimit": "-4.7",
                                                    "upperLimit": "5.5"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-1.1",
                                                    "lowerLimit": "-6.3",
                                                    "upperLimit": "4.1"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 20 Systolic blood pressure",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "31"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "28"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "31"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "1.3",
                                                    "lowerLimit": "-5.8",
                                                    "upperLimit": "8.3"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "1.2",
                                                    "lowerLimit": "-3.6",
                                                    "upperLimit": "6.0"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-1.0",
                                                    "lowerLimit": "-6.2",
                                                    "upperLimit": "4.3"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 24 Systolic blood pressure",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "33"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "35"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-1.0",
                                                    "lowerLimit": "-6.2",
                                                    "upperLimit": "4.1"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-1.1",
                                                    "lowerLimit": "-5.6",
                                                    "upperLimit": "3.4"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-5.9",
                                                    "lowerLimit": "-11.0",
                                                    "upperLimit": "-0.8"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 1 Diastolic blood pressure",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "33"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "35"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.4",
                                                    "lowerLimit": "-2.3",
                                                    "upperLimit": "3.0"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.5",
                                                    "lowerLimit": "-2.6",
                                                    "upperLimit": "3.5"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-2.0",
                                                    "lowerLimit": "-4.6",
                                                    "upperLimit": "0.6"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 2 Diastolic blood pressure",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "34"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "35"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.5",
                                                    "lowerLimit": "0.2",
                                                    "upperLimit": "4.7"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.7",
                                                    "lowerLimit": "-3.1",
                                                    "upperLimit": "1.7"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-1.7",
                                                    "lowerLimit": "-5.0",
                                                    "upperLimit": "1.6"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 4 Diastolic blood pressure",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "35"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "29"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "33"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.0",
                                                    "lowerLimit": "-2.8",
                                                    "upperLimit": "2.8"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.2",
                                                    "lowerLimit": "-2.5",
                                                    "upperLimit": "2.8"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-1.5",
                                                    "lowerLimit": "-4.6",
                                                    "upperLimit": "1.6"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 8 Diastolic blood pressure",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "33"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "29"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "33"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-0.5",
                                                    "lowerLimit": "-3.3",
                                                    "upperLimit": "2.3"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "1.9",
                                                    "lowerLimit": "-1.3",
                                                    "upperLimit": "5.0"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-0.6",
                                                    "lowerLimit": "-3.3",
                                                    "upperLimit": "2.2"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 12 Diastolic blood pressure",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "32"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "29"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "34"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-2.8",
                                                    "lowerLimit": "-6.7",
                                                    "upperLimit": "1.2"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "2.0",
                                                    "lowerLimit": "-1.0",
                                                    "upperLimit": "5.1"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0.9",
                                                    "lowerLimit": "-1.8",
                                                    "upperLimit": "3.6"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 20 Diastolic blood pressure",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "31"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "28"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "31"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.1",
                                                    "lowerLimit": "-1.5",
                                                    "upperLimit": "5.7"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.7",
                                                    "lowerLimit": "-3.9",
                                                    "upperLimit": "2.4"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0.4",
                                                    "lowerLimit": "-3.3",
                                                    "upperLimit": "4.1"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 24 Diastolic blood pressure",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "33"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "35"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "2.2",
                                                    "lowerLimit": "-1.6",
                                                    "upperLimit": "5.9"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.0",
                                                    "lowerLimit": "-2.7",
                                                    "upperLimit": "2.7"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-0.9",
                                                    "lowerLimit": "-3.8",
                                                    "upperLimit": "2.1"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Safety - Changes in Body Temperature From Baseline",
                            "description": "Changes in body temperature are reported The body temperature (\u00baC or \u00baF) was measured according to the site's usual procedure. During treatment phase visits, vital signs were collected before investigational product injection.",
                            "populationDescription": "At certain visits those data are missing for some patients.",
                            "reportingStatus": "POSTED",
                            "paramType": "LEAST_SQUARES_MEAN",
                            "dispersionType": "95% Confidence Interval",
                            "unitOfMeasure": "degree C",
                            "timeFrame": "28 weeks",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Glepaglutide SC Injections Twice Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Placebo SC Injections Twice Weekly",
                                    "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "36"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "Week 1",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "33"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "35"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.0",
                                                    "lowerLimit": "-0.1",
                                                    "upperLimit": "0.2"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.0",
                                                    "lowerLimit": "-0.2",
                                                    "upperLimit": "0.1"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0.1",
                                                    "lowerLimit": "-0.0",
                                                    "upperLimit": "0.2"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 2",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "34"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "32"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "35"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.1",
                                                    "lowerLimit": "-0.0",
                                                    "upperLimit": "0.2"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.0",
                                                    "lowerLimit": "-0.2",
                                                    "upperLimit": "0.1"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0.0",
                                                    "lowerLimit": "-0.1",
                                                    "upperLimit": "0.1"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 4",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "35"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "33"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-0.1",
                                                    "lowerLimit": "-0.2",
                                                    "upperLimit": "0.1"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.0",
                                                    "lowerLimit": "-0.2",
                                                    "upperLimit": "0.1"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0.1",
                                                    "lowerLimit": "-0.1",
                                                    "upperLimit": "0.2"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 8",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "33"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "33"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.0",
                                                    "lowerLimit": "-0.1",
                                                    "upperLimit": "0.2"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.1",
                                                    "lowerLimit": "-0.0",
                                                    "upperLimit": "0.2"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "-0.1",
                                                    "lowerLimit": "-0.2",
                                                    "upperLimit": "0.1"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 12",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "32"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "29"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "33"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-0.0",
                                                    "lowerLimit": "-0.2",
                                                    "upperLimit": "0.1"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.0",
                                                    "lowerLimit": "-0.1",
                                                    "upperLimit": "0.1"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0.1",
                                                    "lowerLimit": "-0.1",
                                                    "upperLimit": "0.2"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 16",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "29"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "32"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "34"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-0.0",
                                                    "lowerLimit": "-0.1",
                                                    "upperLimit": "0.1"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "-0.0",
                                                    "lowerLimit": "-0.1",
                                                    "upperLimit": "0.1"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0.0",
                                                    "lowerLimit": "-0.1",
                                                    "upperLimit": "0.1"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 20",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "31"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "28"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "31"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "0.1",
                                                    "lowerLimit": "-0.1",
                                                    "upperLimit": "0.2"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.0",
                                                    "lowerLimit": "-0.1",
                                                    "upperLimit": "0.1"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0.1",
                                                    "lowerLimit": "-0.1",
                                                    "upperLimit": "0.2"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "Week 24",
                                    "denoms": [
                                        {
                                            "units": "Participants",
                                            "counts": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "33"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "35"
                                                }
                                            ]
                                        }
                                    ],
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "-0.0",
                                                    "lowerLimit": "-0.1",
                                                    "upperLimit": "0.1"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "0.1",
                                                    "lowerLimit": "-0.0",
                                                    "upperLimit": "0.2"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0.1",
                                                    "lowerLimit": "0.0",
                                                    "upperLimit": "0.2"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "type": "SECONDARY",
                            "title": "Immunogenicity - Occurrence of Anti-drug Antibodies",
                            "description": "Occurrence of antibodies against glepaglutide The occurrence of glepaglutide-binding antibodies (ADA), M2 binding antibodies (M2 BAb), glepaglutide neutralizing antibodies (NAb) and GLP-2 cross-reacting antibodies (GLP-2 CR) was tested.",
                            "reportingStatus": "POSTED",
                            "paramType": "COUNT_OF_PARTICIPANTS",
                            "unitOfMeasure": "Participants",
                            "timeFrame": "28 weeks",
                            "groups": [
                                {
                                    "id": "OG000",
                                    "title": "Glepaglutide SC Injections Twice Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog"
                                },
                                {
                                    "id": "OG001",
                                    "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                                    "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide"
                                },
                                {
                                    "id": "OG002",
                                    "title": "Placebo SC Injections Twice Weekly",
                                    "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide"
                                }
                            ],
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "35"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "36"
                                        }
                                    ]
                                }
                            ],
                            "classes": [
                                {
                                    "title": "ADA (Treatment-induced)",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "30"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "31"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "M2 BAb (Treatment-induced)",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "28"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "29"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "NAb M2 (Treatment-induced)",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "10"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "14"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "title": "GLP-2 CR (Treatment-induced)",
                                    "categories": [
                                        {
                                            "measurements": [
                                                {
                                                    "groupId": "OG000",
                                                    "value": "6"
                                                },
                                                {
                                                    "groupId": "OG001",
                                                    "value": "11"
                                                },
                                                {
                                                    "groupId": "OG002",
                                                    "value": "0"
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                "adverseEventsModule": {
                    "frequencyThreshold": "5",
                    "timeFrame": "All AEs, whether serious or non-serious, were to be reported from the time a signed and dated Informed Consent Form (ICF) was obtained until the end of the post-treatment follow-up period on average 28 weeks.",
                    "description": "Due to the long half-life of glepaglutide, all AEs with an onset after the first dose of glepaglutide were treated as 'treatment-emergent', including AEs with an onset during a treatment interruption.\n\nFor the 'Stoma complications' and related preferred terms, the denominators used in the calculation of % are based on patients with small intestine stoma (Glepa 10 mg TW: N=17; Glepa 10 mg OW: N=20; Placebo: N=21).",
                    "eventGroups": [
                        {
                            "id": "EG000",
                            "title": "Glepaglutide SC Injections Twice Weekly",
                            "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 35,
                            "seriousNumAffected": 9,
                            "seriousNumAtRisk": 35,
                            "otherNumAffected": 30,
                            "otherNumAtRisk": 35
                        },
                        {
                            "id": "EG001",
                            "title": "Glepaglutide SC Injections Once Weekly and Placebo Once Weekly",
                            "description": "Intervention: Glepaglutide\n\nglepaglutide: Glucagon-Like Peptide-2 (GLP-2) analog\n\nPlacebo: Placebo for glepaglutide",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 35,
                            "seriousNumAffected": 9,
                            "seriousNumAtRisk": 35,
                            "otherNumAffected": 31,
                            "otherNumAtRisk": 35
                        },
                        {
                            "id": "EG002",
                            "title": "Placebo SC Injections Twice Weekly",
                            "description": "Intervention: Placebo\n\nPlacebo: Placebo for glepaglutide",
                            "deathsNumAffected": 0,
                            "deathsNumAtRisk": 36,
                            "seriousNumAffected": 7,
                            "seriousNumAtRisk": 36,
                            "otherNumAffected": 24,
                            "otherNumAtRisk": 36
                        }
                    ],
                    "seriousEvents": [
                        {
                            "term": "Stoma site haemorrhage",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 17
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 20
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 21
                                }
                            ]
                        },
                        {
                            "term": "Acetabulum fracture",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Alcohol poisoning",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Procedural pneumothorax",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Peripheral arterial occlusive disease",
                            "organSystem": "Vascular disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Dizziness",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Blood loss anaemia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Iron deficiency anaemia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Pyrexia",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Catheter site necrosis",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Hypersensitivity",
                            "organSystem": "Immune system disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Haemorrhoids",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Rectal haemorrhage",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Cholecystitis",
                            "organSystem": "Hepatobiliary disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Device related sepsis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Large intestine infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Vascular device infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 2,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "COVID-19",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Gastrointestinal viral infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Device breakage",
                            "organSystem": "Product Issues",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Device malfunction",
                            "organSystem": "Product Issues",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Metabolic acidosis",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        }
                    ],
                    "otherEvents": [
                        {
                            "term": "Weight decreased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 2,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Aspartate aminotransferase increased",
                            "organSystem": "Investigations",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Stoma site oedema",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 4,
                                    "numAtRisk": 17
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 20
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 21
                                }
                            ]
                        },
                        {
                            "term": "Stoma complication",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 17
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 20
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 21
                                }
                            ]
                        },
                        {
                            "term": "Stomal hernia",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 17
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 20
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 21
                                }
                            ]
                        },
                        {
                            "term": "Procedural pain",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Fall",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Stoma site irritation",
                            "organSystem": "Injury, poisoning and procedural complications",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 17
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 20
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 21
                                }
                            ]
                        },
                        {
                            "term": "Headache",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 4,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 3,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Dizziness",
                            "organSystem": "Nervous system disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Injection site reaction",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 9,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 15,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Injection site erythema",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 5,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 6,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Pyrexia",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 4,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Fatigue",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 4,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 4,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Injection site pain",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 4,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 3,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Injection site induration",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 4,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Oedema peripheral",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 4,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 2,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Injection site irritation",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 3,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Feeling hot",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Injection site rash",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Malaise",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Injection site pruritus",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 4,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Complication associated with device",
                            "organSystem": "General disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Iron deficiency anaemia",
                            "organSystem": "Blood and lymphatic system disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Nausea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 7,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 3,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Abdominal pain",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 5,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 6,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 2,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Vomiting",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 3,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 6,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Abdominal discomfort",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 2,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Dry mouth",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Diarrhoea",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Abdominal distension",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Abdominal pain lower",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Oropharyngeal pain",
                            "organSystem": "Gastrointestinal disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Rash",
                            "organSystem": "Skin and subcutaneous tissue disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Muscle spasms",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 3,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Back pain",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Osteoporosis",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Arthralgia",
                            "organSystem": "Musculoskeletal and connective tissue disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 3,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Urinary tract infection",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 2,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Nasopharyngitis",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 3,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Gastrointestinal bacterial overgrowth",
                            "organSystem": "Infections and infestations",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 3,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Dehydration",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 4,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 1,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 0,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Hypomagnesaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 2,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 1,
                                    "numAtRisk": 36
                                }
                            ]
                        },
                        {
                            "term": "Hyperuricaemia",
                            "organSystem": "Metabolism and nutrition disorders",
                            "sourceVocabulary": "MedDRA 24.1",
                            "assessmentType": "SYSTEMATIC_ASSESSMENT",
                            "stats": [
                                {
                                    "groupId": "EG000",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG001",
                                    "numAffected": 0,
                                    "numAtRisk": 35
                                },
                                {
                                    "groupId": "EG002",
                                    "numAffected": 2,
                                    "numAtRisk": 36
                                }
                            ]
                        }
                    ]
                },
                "moreInfoModule": {
                    "certainAgreement": {
                        "piSponsorEmployee": false,
                        "restrictiveAgreement": false
                    },
                    "pointOfContact": {
                        "title": "Head of clinical operations",
                        "organization": "Zealand Pharma A/S",
                        "email": "info@zealandpharma.com",
                        "phone": "+45 8877 3600"
                    }
                }
            },
            "documentSection": {
                "largeDocumentModule": {
                    "largeDocs": [
                        {
                            "typeAbbrev": "Prot",
                            "hasProtocol": true,
                            "hasSap": false,
                            "hasIcf": false,
                            "label": "Study Protocol",
                            "date": "2022-01-27",
                            "uploadDate": "2024-08-02T10:37",
                            "filename": "Prot_001.pdf",
                            "size": 4131506
                        },
                        {
                            "typeAbbrev": "SAP",
                            "hasProtocol": false,
                            "hasSap": true,
                            "hasIcf": false,
                            "label": "Statistical Analysis Plan",
                            "date": "2022-08-25",
                            "uploadDate": "2024-08-02T10:43",
                            "filename": "SAP_002.pdf",
                            "size": 725859
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18",
                    "removedCountries": [
                        "Italy"
                    ],
                    "submissionTracking": {
                        "firstMcpInfo": {
                            "postDateStruct": {
                                "date": "2024-06-25",
                                "type": "ACTUAL"
                            }
                        }
                    }
                },
                "conditionBrowseModule": {
                    "meshes": [
                        {
                            "id": "D012778",
                            "term": "Short Bowel Syndrome"
                        },
                        {
                            "id": "D013577",
                            "term": "Syndrome"
                        }
                    ],
                    "ancestors": [
                        {
                            "id": "D004194",
                            "term": "Disease"
                        },
                        {
                            "id": "D010335",
                            "term": "Pathologic Processes"
                        },
                        {
                            "id": "D008286",
                            "term": "Malabsorption Syndromes"
                        },
                        {
                            "id": "D007410",
                            "term": "Intestinal Diseases"
                        },
                        {
                            "id": "D005767",
                            "term": "Gastrointestinal Diseases"
                        },
                        {
                            "id": "D004066",
                            "term": "Digestive System Diseases"
                        },
                        {
                            "id": "D011183",
                            "term": "Postoperative Complications"
                        }
                    ],
                    "browseLeaves": [
                        {
                            "id": "M16355",
                            "name": "Syndrome",
                            "asFound": "Syndrome",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M15586",
                            "name": "Short Bowel Syndrome",
                            "asFound": "Short Bowel Syndrome",
                            "relevance": "HIGH"
                        },
                        {
                            "id": "M11278",
                            "name": "Malabsorption Syndromes",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M10444",
                            "name": "Intestinal Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M8883",
                            "name": "Gastrointestinal Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M7255",
                            "name": "Digestive System Diseases",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M14065",
                            "name": "Postoperative Complications",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T5206",
                            "name": "Short Bowel Syndrome",
                            "asFound": "Short Bowel Syndrome",
                            "relevance": "HIGH"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "BC23",
                            "name": "Symptoms and General Pathology"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Conditions"
                        },
                        {
                            "abbrev": "BC06",
                            "name": "Digestive System Diseases"
                        },
                        {
                            "abbrev": "BC18",
                            "name": "Nutritional and Metabolic Diseases"
                        },
                        {
                            "abbrev": "Rare",
                            "name": "Rare Diseases"
                        }
                    ]
                },
                "interventionBrowseModule": {
                    "browseLeaves": [
                        {
                            "id": "M9043",
                            "name": "Glucagon",
                            "relevance": "LOW"
                        },
                        {
                            "id": "M26997",
                            "name": "Glucagon-Like Peptide 1",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "Gast",
                            "name": "Gastrointestinal Agents"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        }
                    ]
                }
            },
            "hasResults": true
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT03978806",
                    "orgStudyIdInfo": {
                        "id": "20-0419"
                    },
                    "organization": {
                        "fullName": "University of Colorado, Denver",
                        "class": "OTHER"
                    },
                    "briefTitle": "Prosperando: Fostering Resilience on Dialysis",
                    "officialTitle": "Fostering Resilience on Dialysis: A Peer Navigator Study to Improve the Well-being of Latinos on Hemodialysis"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2020-10-05",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2024-07-07",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2024-07-07",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2019-05-30",
                    "studyFirstSubmitQcDate": "2019-06-05",
                    "studyFirstPostDateStruct": {
                        "date": "2019-06-07",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-18",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "University of Colorado, Denver",
                        "class": "OTHER"
                    },
                    "collaborators": [
                        {
                            "name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
                            "class": "NIH"
                        }
                    ]
                },
                "oversightModule": {
                    "oversightHasDmc": true,
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "Latinos with End-Stage Renal Disease (ESRD) represent 17% of the US adult ESRD community and suffer a disproportionate burden of social challenges that impacts their well-being. With support from the Amos award from the Robert Wood Johnson Foundation (RWJF), the investigators assessed the feasibility of a 1-arm intervention of a 5-visit lay Peer Navigator intervention to support Latino ESRD patients with social challenges and adherence (using motivational interviewing \\& patient activation). This trial will build on the Amos work as a small Randomized Controlled Trial (RCT). The overall aims of this proposal are to: 1) engage key operational and clinical stakeholders early-on to develop a Peer Navigator-intervention; 2) conduct a pilot RCT of the peer navigator intervention versus standard care to test feasibility and acceptability; and 3) assess the efficacy of the intervention on interdialytic weight gain (primary outcome) as well as health-related quality of life, patient activation, and hemodialysis adherence (secondary outcomes).",
                    "detailedDescription": "The goal of this project is to assess the feasibility and acceptability of a pilot RCT of a culturally tailored peer-navigator (PN) intervention to improve patient-centered and clinical outcomes for Latino patients with end-stage kidney disease (ESKD). We will compare a culturally tailored intervention that includes a PN to control (standard care). In the culturally tailored intervention, the bilingual PN will provide support with social challenges during 5 visits. We will assess the feasibility of (1) referral, (2) recruitment, (3) retention, (4) intervention implementation, and (5) data collection. We will also assess various outcomes including inter-dialytic weight gain and other adherence and patient-centered outcomes.\n\nSpecific Aim 1: Conduct a pilot RCT of the peer navigator intervention to assess feasibility, acceptability, as well as outcomes of the proposed peer navigator intervention.\n\nHypothesis 1: A culturally tailored intervention that consists of a bilingual/culture-concordant peer navigator that provides support with social challenges and support with adherence using motivational interviewing for Latino end-stage kidney disease (ESKD) patients, is feasible and acceptable."
                },
                "conditionsModule": {
                    "conditions": [
                        "Racial/Ethnic Minorities on Dialysis"
                    ],
                    "keywords": [
                        "Latino",
                        "Hispanic",
                        "Dialysis",
                        "Navigator",
                        "Community health worker"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "NA"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "interventionModelDescription": "This will be a pilot RCT (randomized controlled trial) of a 3 month intervention of Latino ESRD patients that will be randomized to one of two arms: 1) PN Arm, in which a bilingual PN provides support with social factors and support with adherence using motivational interviewing during 5 visits or 2) Control (standard care) Arm.",
                        "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
                        "maskingInfo": {
                            "masking": "SINGLE",
                            "maskingDescription": "The PI will not know arm assignment.",
                            "whoMasked": [
                                "INVESTIGATOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 139,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "peer navigator",
                            "type": "ACTIVE_COMPARATOR",
                            "description": "The first PN visit will take place within 1-2 weeks of consent. Each of the 5 subsequent PN visits will take place every 1-2 weeks. We expect patients to complete the intervention within 2-3 months of consent. The function of the initial visit is to establish trust and ensure a more personal approach with participants. The community-based PN intervention is grounded in core Latino values (e.g. trust, personalized relationships). The core elements of the PN intervention include patient motivational interviewing as well as patient activation, empowerment (e.g. help with scheduling of healthcare appointments and re-scheduling of missed HD sessions), education (e.g. education of ESKD and need for renal replacement therapy), and social challenges (e.g. access to resources for transportation, benefits, immigration issues). The duration, individuals present during the visit, and content discussed will be documented in the visit form.",
                            "interventionNames": [
                                "Behavioral: Active Comparator: peer navigator"
                            ]
                        },
                        {
                            "label": "Control Arm (standard of care)",
                            "type": "PLACEBO_COMPARATOR",
                            "description": "Standard of care",
                            "interventionNames": [
                                "Other: Placebo Comparator: Control Arm (standard of care)"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "BEHAVIORAL",
                            "name": "Active Comparator: peer navigator",
                            "description": "The intervention is aimed to provide support with social challenges and adherence. The peer navigator will meet with patients to provide support with social challenges and use motivational interviewing to provide support with adherence.",
                            "armGroupLabels": [
                                "peer navigator"
                            ]
                        },
                        {
                            "type": "OTHER",
                            "name": "Placebo Comparator: Control Arm (standard of care)",
                            "description": "Control patients will have met the same inclusion and exclusion criteria as intervention patients.",
                            "armGroupLabels": [
                                "Control Arm (standard of care)"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Interdialytic weight gain",
                            "description": "Inter-dialytic weight gain will be calculated as the monthly average of the difference between the pre-dialysis weight and the weight at the end of the previous dialysis session, divided by determined dry weight, expressed as a percentage of change in weight per day (%\u0394kg per day).",
                            "timeFrame": "Data collection 3 months prior to consent (collected retrospectively) and 6 months following study completion"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "Kidney Dialysis Quality of Life Short Form - 36 questions",
                            "description": "KDQOL(Kidney Disease Quality Of Life) - Short Form 36 (SF-36). The KDQOL Short Form-36 (KDQOL-SF-36), a 36 item survey with five subscales (Physical Component Summary, Mental Component Summary, Burden of Kidney Disease subscale, Symptoms and Problems subscale, and Effects of Kidney Disease on Daily Life). The KDQOL-SF-36 are scored linearly (with higher score indicating better quality of life) on a range of 0-100 using the developer-recommended scoring (available at https://www.rand.org/health-care/surveys_tools/kdqol.html).",
                            "timeFrame": "Change from baseline health-related quality of life up to 24 months"
                        },
                        {
                            "measure": "Hemodialysis shortening",
                            "description": "Hemodialysis shortening: Defined as shortening the hemodialysis session by greater than or equal to 10 minutes.",
                            "timeFrame": "This will be monitored beginning 3 months prior to enrollment and then 3 months following study completion up to 24 months. Detailed: Monthly for 3 months prior to enrollment, monthly during study and then monthly for 3 months after study completion."
                        },
                        {
                            "measure": "Hemodialysis adherence",
                            "description": "Hemodialysis adherence defined defined as the proportion of monthly scheduled sessions missed (other than for vacation or hospitalization)",
                            "timeFrame": "This will be monitored beginning 3 months prior to enrollment and then 3 months following study completion up to 24 months. Detailed: Monthly for 3 months prior to enrollment, monthly during study and then monthly for 3 months after study completion."
                        },
                        {
                            "measure": "Albumin",
                            "description": "Albumin",
                            "timeFrame": "This will be monitored beginning 3 months prior to enrollment and then 3 months following study completion up to 24 months. Detailed: Monthly for 3 months prior to enrollment, monthly during study and then monthly for 3 months after study completion."
                        },
                        {
                            "measure": "Potassium",
                            "description": "Potassium",
                            "timeFrame": "This will be monitored beginning 3 months prior to enrollment and then 3 months following study completion up to 24 months. Detailed: Monthly for 3 months prior to enrollment, monthly during study and then monthly for 3 months after study completion."
                        },
                        {
                            "measure": "Phosphorus",
                            "description": "Phosphorus",
                            "timeFrame": "Assessed 3 months prior to enrollment, monitored monthly during intervention, and followed for 3 months after intervention"
                        },
                        {
                            "measure": "Social determinants of health composite survey",
                            "description": "Several questions from various previously validated surveys that assess social determinants of health.",
                            "timeFrame": "Assessed at twice: At time of enrollment and at time of study completion (up to 1 year)"
                        },
                        {
                            "measure": "Self-Efficacy",
                            "description": "Patient-Reported Outcomes Measurement Information System (PROMIS) measure to assess self-efficacy",
                            "timeFrame": "Assessed at twice: At time of enrollment and at time of study completion (up to 1 year)"
                        },
                        {
                            "measure": "Patient Activation Measure",
                            "description": "Patient Activation Measure has 13 questions, each item is rated on a four-point scale (1 strong disagree to 4 strong agree, with additional 'non-applicable.' Level 1 (less than 47) indicates 'not believing activation is important.' Level 2 (47 to 55.1) indicates 'a lack of knowledge and confidence to take action.' Level 3 (55.2 to 67) indicates 'beginning to take action.' Level 4 (greater than 67) indicates 'taking action.'",
                            "timeFrame": "Assessed at twice: At time of enrollment and at time of study completion (up to 1 year)"
                        },
                        {
                            "measure": "Emergency Department visits and hospitalizations",
                            "description": "Number of Emergency Department (ED) visits and hospitalizations, length of stay",
                            "timeFrame": "Assessed at twice: At time of enrollment and at time of study completion (up to 1 year)"
                        },
                        {
                            "measure": "Social Isolation",
                            "description": "PROMIS measure",
                            "timeFrame": "Assessed twice: At time of enrollment and at time of study completion (up to 1 year)"
                        },
                        {
                            "measure": "Qualitative interviews to assess acceptability",
                            "description": "10 participants will be interviewed using semi-structured approach. The results will be a thematic analysis (that ties in the themes and subthemes with illustrative quotes).",
                            "timeFrame": "Assessed twice: At time of enrollment and at time of study completion (up to 1 year)"
                        },
                        {
                            "measure": "Kidney transplantation Questions derived/tailored from two previously published questionnaires.",
                            "description": "Kidney transplantation interest in pursuing, placement on list, receipt of transplantation. Questions were derived and tailored from two studies: Ayanian NEJM 1999;341:1661-9 \\& Bouleware American J of Transplantation 2005;5:1503-1512. Some are yes/no questions and others are on a Likert Scale.",
                            "timeFrame": "Assessed twice: At time of enrollment and at time of study completion (up to 1 year)"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Self-identify as Latino\n2. Age between 18 and 90 years\n3. Diagnosed with end-stage kidney disease\n4. Received standard (thrice-weekly HD) for at least 3 months\n5. No active substance use (e.g. heavy etoh or opiates)\n6. Speak English or Spanish as a primary language\n7. Participants must be able to provide informed consent\n\nExclusion Criteria:\n\n1. Active suicidal intent\n2. Present or past psychosis or bipolar disorder\n3. Patient to receive kidney transplantation in the next 3 months",
                    "healthyVolunteers": true,
                    "sex": "ALL",
                    "minimumAge": "18 Years",
                    "maximumAge": "90 Years",
                    "stdAges": [
                        "ADULT",
                        "OLDER_ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "locations": [
                        {
                            "facility": "Fresenius Medical Care Rocky Mountain Dialysis",
                            "city": "Denver",
                            "state": "Colorado",
                            "zip": "80220",
                            "country": "United States",
                            "geoPoint": {
                                "lat": 39.73915,
                                "lon": -104.9847
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "24115478",
                            "type": "BACKGROUND",
                            "citation": "Cukor D, Ver Halen N, Asher DR, Coplan JD, Weedon J, Wyka KE, Saggi SJ, Kimmel PL. Psychosocial intervention improves depression, quality of life, and fluid adherence in hemodialysis. J Am Soc Nephrol. 2014 Jan;25(1):196-206. doi: 10.1681/ASN.2012111134. Epub 2013 Oct 10."
                        },
                        {
                            "pmid": "22841929",
                            "type": "BACKGROUND",
                            "citation": "Lora CM, Ricardo AC, Brecklin CS, Fischer MJ, Rosman RT, Carmona E, Lopez A, Balaram M, Nessel L, Tao KK, Xie D, Kusek JW, Go AS, Lash JP. Recruitment of Hispanics into an observational study of chronic kidney disease: the Hispanic Chronic Renal Insufficiency Cohort Study experience. Contemp Clin Trials. 2012 Nov;33(6):1238-44. doi: 10.1016/j.cct.2012.07.012. Epub 2012 Jul 27."
                        },
                        {
                            "pmid": "28404600",
                            "type": "BACKGROUND",
                            "citation": "Cervantes L, Jones J, Linas S, Fischer S. Qualitative Interviews Exploring Palliative Care Perspectives of Latinos on Dialysis. Clin J Am Soc Nephrol. 2017 May 8;12(5):788-798. doi: 10.2215/CJN.10260916. Epub 2017 Apr 12."
                        },
                        {
                            "pmid": "26612276",
                            "type": "BACKGROUND",
                            "citation": "Cervantes L, Linas S, Keniston A, Fischer S. Latinos With Chronic Kidney Failure Treated by Dialysis: Understanding Their Palliative Care Perspectives. Am J Kidney Dis. 2016 Feb;67(2):344-7. doi: 10.1053/j.ajkd.2015.09.026. Epub 2015 Nov 20. No abstract available."
                        },
                        {
                            "pmid": "30702365",
                            "type": "BACKGROUND",
                            "citation": "Cervantes L, Chonchol M, Hasnain-Wynia R, Steiner JF, Havranek E, Hull M, Rice J, Kendrick J, Alamillo X, Camacho C, Fischer S. Peer Navigator Intervention for Latinos on Hemodialysis: A Single-Arm Clinical Trial. J Palliat Med. 2019 Jul;22(7):838-843. doi: 10.1089/jpm.2018.0439. Epub 2019 Jan 31."
                        },
                        {
                            "pmid": "29847204",
                            "type": "BACKGROUND",
                            "citation": "Cervantes L, Hull M, Keniston A, Chonchol M, Hasnain-Wynia R, Fischer S. Symptom Burden among Latino Patients with End-Stage Renal Disease and Access to Standard or Emergency-Only Hemodialysis. J Palliat Med. 2018 Sep;21(9):1329-1333. doi: 10.1089/jpm.2017.0663. Epub 2018 May 30."
                        },
                        {
                            "pmid": "30550077",
                            "type": "BACKGROUND",
                            "citation": "Cervantes L, Zoucha J, Jones J, Fischer S. Experiences and Values of Latinos with End Stage Renal Disease: A Systematic Review of Qualitative Studies. Nephrol Nurs J. 2016 Nov-Dec;43(6):479-493."
                        },
                        {
                            "pmid": "25240788",
                            "type": "BACKGROUND",
                            "citation": "Fischer SM, Cervantes L, Fink RM, Kutner JS. Apoyo con Carino: a pilot randomized controlled trial of a patient navigator intervention to improve palliative care outcomes for Latinos with serious illness. J Pain Symptom Manage. 2015 Apr;49(4):657-65. doi: 10.1016/j.jpainsymman.2014.08.011. Epub 2014 Sep 18."
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "UNDECIDED",
                    "description": "There is no plan to share individual participant data at this time. If this changes, this section will be modified."
                }
            },
            "documentSection": {
                "largeDocumentModule": {
                    "largeDocs": [
                        {
                            "typeAbbrev": "ICF",
                            "hasProtocol": false,
                            "hasSap": false,
                            "hasIcf": true,
                            "label": "Informed Consent Form",
                            "date": "2020-05-11",
                            "uploadDate": "2020-09-25T11:31",
                            "filename": "ICF_000.pdf",
                            "size": 219147
                        }
                    ]
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT04527406",
                    "orgStudyIdInfo": {
                        "id": "HEMI 1.1"
                    },
                    "organization": {
                        "fullName": "Children's Hospital of Fudan University",
                        "class": "OTHER"
                    },
                    "briefTitle": "Early Surgical Intervention of Congenital Hemivertebra in Young Children",
                    "officialTitle": "Early Hemivertebra Resection of Congenital Hemivertebra in Very Young Children: A Randomized Clinical Study"
                },
                "statusModule": {
                    "statusVerifiedDate": "2024-10",
                    "overallStatus": "NOT_YET_RECRUITING",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2025-03-01",
                        "type": "ESTIMATED"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2027-12-30",
                        "type": "ESTIMATED"
                    },
                    "completionDateStruct": {
                        "date": "2028-12-30",
                        "type": "ESTIMATED"
                    },
                    "studyFirstSubmitDate": "2020-08-24",
                    "studyFirstSubmitQcDate": "2020-08-25",
                    "studyFirstPostDateStruct": {
                        "date": "2020-08-26",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-18",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "Children's Hospital of Fudan University",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "Early treatment of congenital hemivertebrae is very important. The investigators design this study to figure out how early hemivertebrae resection be apply to children. Children aged 3-5 years old diagnosed as congenital hemivertebrae will be randomly divided into early operation group and control group. The early operation group will undergo posterior hemivertebra resection. The control group received brace plaster fixation to reduce the progression of scoliosis, and then will undergo operation after 5 years old. Primary Outcome Measure is the length of spine surgery.",
                    "detailedDescription": "Early diagnosis and early effective treatment of congenital hemivertebrae can correct the deformities.Therefore, traditionally, children with a clear diagnosis should be fixed with a brace to delay the aggravation of scoliosis and then undergo surgery after 5 years of age. The design of this study is to conduct a single-center randomized controlled study. Children aged 3-5 years old diagnosed as congenital hemivertebrae will be randomly divided into the early operation group and the control group. The early operation group will undergo posterior hemivertebra resection. The control group received brace plaster fixation to reduce the progression of scoliosis, and posterior scoliosis correction will be performed after the age was over 5 years old. The primary outcome measures are the length of spine surgery for the two groups of children. The secondary outcome measures are change of scoliosis cobb angle, by comparing preoperative and postoperative cobb angle changes. It is expected that the early treatment group will shorten the length of surgery due to the smaller degree of scoliosis. Our research is expected to broaden the age-adaptation of classic spinal surgery in the field of pediatric spine."
                },
                "conditionsModule": {
                    "conditions": [
                        "Congenital Hemivertebra"
                    ],
                    "keywords": [
                        "Congenital hemivertebra",
                        "Young Children",
                        "posterior hemivertebra resection"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "NA"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "interventionModelDescription": "The research subjects are randomly assigned to the early surgery group (experimental group) or traditional surgery group (control group) at a ratio of 1:1",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "SINGLE",
                            "maskingDescription": "Outcomes Assessor conduct independent statistical analysis and evaluation",
                            "whoMasked": [
                                "OUTCOMES_ASSESSOR"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 60,
                        "type": "ESTIMATED"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Early surgical group",
                            "type": "EXPERIMENTAL",
                            "description": "The subjects in this group received early surgical treatment, and they are arranged to be admitted to the hospital for surgical treatment after admission. The operation choice is posterior hemivertebrae resection + posterior pedicle screw placement + scoliosis correction.",
                            "interventionNames": [
                                "Procedure: posterior hemivertebra resection"
                            ]
                        },
                        {
                            "label": "Traditional surgical treatment",
                            "type": "ACTIVE_COMPARATOR",
                            "description": "This group of subjects received conservative treatment with custom-made braces to delay the progression of scoliosis. It is planned to use the classic posterior hemivertebrae resection + posterior pedicle screw placement + scoliosis correction to complete the correction around the age of 5.",
                            "interventionNames": [
                                "Procedure: conservative treatment+ delayed posterior hemivertebra resection"
                            ]
                        }
                    ],
                    "interventions": [
                        {
                            "type": "PROCEDURE",
                            "name": "posterior hemivertebra resection",
                            "description": "The subjects in early surgical group are arranged to be admitted to for surgical treatment very soon. The operation choice is posterior hemivertebrae resection + posterior pedicle screw placement + scoliosis correction. During operation pedicle screws are placed in the adjacent vertebrae of the head and tail of the Hemivertebra. Wedge resection of the hemivertebrae is performed afterward. Finally, two rods are placed between the pedicle screws. Intraoperative fluoroscopy confirms that the internal fixation position is good.",
                            "armGroupLabels": [
                                "Early surgical group"
                            ]
                        },
                        {
                            "type": "PROCEDURE",
                            "name": "conservative treatment+ delayed posterior hemivertebra resection",
                            "description": "In traditional surgical group, subjects received conservative treatment firstly with custom-made braces to delay the progression of scoliosis. It is planned to use the classic posterior hemivertebrae resection + posterior pedicle screw placement + scoliosis correction to complete the correction around the age of 5. The operation choice is identical with early surgical group. During operation pedicle screws are placed in the adjacent vertebrae of the head and tail of the Hemivertebra. Wedge resection of the hemivertebrae is performed afterward. Finally, two rods are placed between the pedicle screws. Intraoperative fluoroscopy confirms that the internal fixation position is good.",
                            "armGroupLabels": [
                                "Traditional surgical treatment"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Duration of surgery",
                            "description": "The length of posterior hemivertebra resection operation time, acquired in the operation record from hospital",
                            "timeFrame": "The operation time\uff1a from the beginning of the surgical skinning to the end of the surgical suture"
                        }
                    ],
                    "secondaryOutcomes": [
                        {
                            "measure": "change of scoliosis cobb angle",
                            "description": "X-ray measurement of scoliosis cobb angle, by compare the preoperative and postoperative cobb angle changes to obtain the degree of scoliosis correction",
                            "timeFrame": "intraoperative"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* Single-segment thoracic or lumbar hemivertebrae scoliosis diagnosed by X-ray and CT.\n\nExclusion Criteria:\n\n* Diagnosed with syndrome of scoliosis, osteochondrodysplasia, multi-segment hemivertebrae deformity, cervical hemivertebrae deformity",
                    "healthyVolunteers": false,
                    "sex": "ALL",
                    "minimumAge": "3 Years",
                    "maximumAge": "5 Years",
                    "stdAges": [
                        "CHILD"
                    ]
                },
                "contactsLocationsModule": {
                    "centralContacts": [
                        {
                            "name": "Junrong Meng, MD",
                            "role": "CONTACT",
                            "phone": "15121013103",
                            "phoneExt": "+86",
                            "email": "mengjunrong@fudan.edu.cn"
                        },
                        {
                            "name": "Dahui Wang, MD-PhD",
                            "role": "CONTACT",
                            "phone": "18017591060",
                            "phoneExt": "+86",
                            "email": "wangdahui@fudan.edu.cn"
                        }
                    ],
                    "overallOfficials": [
                        {
                            "name": "Dahui Wang, MD-PhD",
                            "affiliation": "Children's hospital of fudan uviversity, shanghai, China",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "17513957",
                            "type": "BACKGROUND",
                            "citation": "Ginsburg G, Mulconrey DS, Browdy J. Transpedicular hemiepiphysiodesis and posterior instrumentation as a treatment for congenital scoliosis. J Pediatr Orthop. 2007 Jun;27(4):387-91. doi: 10.1097/01.bpb.0000271312.95621.b0."
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO",
                    "description": "depend on correspond"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                }
            },
            "hasResults": false
        },
        {
            "protocolSection": {
                "identificationModule": {
                    "nctId": "NCT05485506",
                    "orgStudyIdInfo": {
                        "id": "278CER22"
                    },
                    "organization": {
                        "fullName": "University of the Balearic Islands",
                        "class": "OTHER"
                    },
                    "briefTitle": "Multimodal Exercises on Sprint Performance of Rugby Players",
                    "officialTitle": "Effects of a Multimodal Exercise Program on the Kinematics and Sprint Performance of Young Rugby Players: an Experimental Study."
                },
                "statusModule": {
                    "statusVerifiedDate": "2022-07",
                    "overallStatus": "COMPLETED",
                    "expandedAccessInfo": {
                        "hasExpandedAccess": false
                    },
                    "startDateStruct": {
                        "date": "2022-08-08",
                        "type": "ACTUAL"
                    },
                    "primaryCompletionDateStruct": {
                        "date": "2022-08-08",
                        "type": "ACTUAL"
                    },
                    "completionDateStruct": {
                        "date": "2022-09-25",
                        "type": "ACTUAL"
                    },
                    "studyFirstSubmitDate": "2022-07-30",
                    "studyFirstSubmitQcDate": "2022-08-02",
                    "studyFirstPostDateStruct": {
                        "date": "2022-08-03",
                        "type": "ACTUAL"
                    },
                    "lastUpdateSubmitDate": "2024-10-17",
                    "lastUpdatePostDateStruct": {
                        "date": "2024-10-21",
                        "type": "ACTUAL"
                    }
                },
                "sponsorCollaboratorsModule": {
                    "responsibleParty": {
                        "type": "SPONSOR"
                    },
                    "leadSponsor": {
                        "name": "University of the Balearic Islands",
                        "class": "OTHER"
                    }
                },
                "oversightModule": {
                    "isFdaRegulatedDrug": false,
                    "isFdaRegulatedDevice": false
                },
                "descriptionModule": {
                    "briefSummary": "This study is designed to evaluate the effects of a multimodal exercise program in the sprint performance and kinematics of adolescent rugby players. For this, an experimental study with an intervention group (IG) and a control group (CG) is designed. During 6 weeks of the 2022-2023 preseason of rugby seven, IG will include a multimodal exercise program in their training routine. Meanwhile, CG will maintain their training routine. The study will be developed in the Sport High Performance Centre of Balearic Islands during the season of rugby seven (from August to September, 2022). All rugby athletes from under-16 and under-18 autonomic rugby teams will be invited to participate in this study throughout an email invitation from their regional rugby federation. Prior to the beginning of the study, all participants will sign the inform consent, or their legal tutors in case of minors. The Ethical Committee of the local university approved this study (278CER22) according to the Declaration of Helsinki.\n\nOne week before intervention period, sociodemographic and sportive data will be registered (age, sex, body mass, height, and sport experience). Body mass and height will be evaluated with a \u00b1100-g precision digital weight scale (Tefal, France) and a t201-t4 adult height scale (Asimed, Spain), respectively. Also, the rugby players will complete a familiarization process consisting on a standardized warm up and 3 progressive sprints (i.e. 30 m at 50%, 70% and 90% of maximal effort).\n\nAll testing procedure (pre-test and post-test) will be completed at a similar daytime (between 17h and 19h) on the same natural grass field. The test procedure listed in our study will consist on two maximal 30-m sprints to obtain mechanical variables of horizontal force-velocity profile and kinematics during sprinting.\n\nPlayers from IG will perform a multimodal exercise program two days per week during six weeks. This program will include running technical drills, exercises for lumbopelvic stabilization and resisted sprints. This program will be supervised by two experts in this field.\n\nThe investigators hypothesize that those rugby players who add the multimodal exercise program to their training routine will increase mechanical and kinematics variables of sprint performance."
                },
                "conditionsModule": {
                    "conditions": [
                        "Exercise Training",
                        "Rugby",
                        "Adolescent"
                    ],
                    "keywords": [
                        "sprint performance",
                        "strength training",
                        "sprint kinematics"
                    ]
                },
                "designModule": {
                    "studyType": "INTERVENTIONAL",
                    "phases": [
                        "NA"
                    ],
                    "designInfo": {
                        "allocation": "RANDOMIZED",
                        "interventionModel": "PARALLEL",
                        "primaryPurpose": "TREATMENT",
                        "maskingInfo": {
                            "masking": "SINGLE",
                            "whoMasked": [
                                "PARTICIPANT"
                            ]
                        }
                    },
                    "enrollmentInfo": {
                        "count": 24,
                        "type": "ACTUAL"
                    }
                },
                "armsInterventionsModule": {
                    "armGroups": [
                        {
                            "label": "Intervention group",
                            "type": "EXPERIMENTAL",
                            "description": "Intervention group will add to their training routine a multimodal exercise program (two days per week, during six weeks). This program will include running technical drills, exercises for lumbopelvic stabilization and resisted sprints by using sled.",
                            "interventionNames": [
                                "Other: Multimodal exercise program"
                            ]
                        },
                        {
                            "label": "Control group",
                            "type": "NO_INTERVENTION",
                            "description": "Control group will maintain their training routine."
                        }
                    ],
                    "interventions": [
                        {
                            "type": "OTHER",
                            "name": "Multimodal exercise program",
                            "description": "Running technical drills: pogo, askip, dribble, scissor, etc. Exercises for lumbopelvic stabilization: mobility exercises, hip thrust, dead lift, lunge to skip.\n\nResisted sprints by using a sled: resistance leading to a 60% and 30% of optimal load (previously calculated)",
                            "armGroupLabels": [
                                "Intervention group"
                            ]
                        }
                    ]
                },
                "outcomesModule": {
                    "primaryOutcomes": [
                        {
                            "measure": "Sprint performance",
                            "description": "Sprint performance measured with MySprint. Resulting from maximal 30-m sprint, six pairs of brands with parallax corrected will be placed at 0, 5, 10, 15, 20 and 30 m to measure the five different split times in seconds during the 30-m trials. The camera, which records 240 frame per second, will be situated on a tripod (in the sagittal plane) 10 meters away from the fourth marker in meter 15.",
                            "timeFrame": "Change from baseline and between group differences in sprint performance after the intervention period of 6 weeks"
                        },
                        {
                            "measure": "Force-Velocity Profile (F-V)",
                            "description": "F-V Profile measured by My Sprint App, resulting from maximal 30-m sprint, theorical maximal horizontal force (F0), maximal mechanical power output in the horizontal direction (Pmax), rate of decrease in RF with increasing speed during sprint acceleration (DRF), Slope of the linear F-V relationship (Sfv), Ratio of force (RF) and maximal value of RF (RFmax). The camera, which records 240 frame per second, will be situated on a tripod (in the sagittal plane) 10 meters away from the fourth marker in meter 15.",
                            "timeFrame": "Change from baseline and between group differences in horizontal force-velocity profile after the intervention period of 6 weeks"
                        },
                        {
                            "measure": "Sprint spatiotemporal and kinematics",
                            "description": "Sprint spatiotemporal and kinematics will be analyzed with Kinovea program (v.0.8.15). The following variables will be analyzed: contact time (s), length step (m; horizontal displacement between the toe tips at adjacent touchdowns), step rate (Hz; the reciprocal of step duration). Moreover, in the frame that the foot touchdown and the frame that the foot touch off trunk and hip (ipsilateral and contralateral) angles will be quantified. The camera, which records 240 frame per second, will be situated 9 meters away from 22.5 m on a tripod at a height of 1.1 meters in the sagittal plane.",
                            "timeFrame": "Change from baseline and between groups in sprint spatiotemporal and kinematics at 6 weeks"
                        }
                    ]
                },
                "eligibilityModule": {
                    "eligibilityCriteria": "Inclusion Criteria:\n\n* to have at least 14 years old\n* to have at least 2 years of experience as rugby player\n\nExclusion Criteria:\n\n* to have sustained a lower limb or lumbopelvic injury during the previous 6 months to start of the study\n* to have sustained a lower limb or spine surgery during the previous 12 months to start of the study",
                    "healthyVolunteers": true,
                    "sex": "ALL",
                    "minimumAge": "14 Years",
                    "maximumAge": "18 Years",
                    "stdAges": [
                        "CHILD",
                        "ADULT"
                    ]
                },
                "contactsLocationsModule": {
                    "overallOfficials": [
                        {
                            "name": "Natalia Romero Franco, PhD",
                            "affiliation": "University of the Balearic Islands",
                            "role": "STUDY_DIRECTOR"
                        }
                    ],
                    "locations": [
                        {
                            "facility": "Sport High Performance Centre of Balearic Islands",
                            "city": "Palma De Mallorca",
                            "state": "Islas Baleares",
                            "zip": "07009",
                            "country": "Spain",
                            "geoPoint": {
                                "lat": 39.56939,
                                "lon": 2.65024
                            }
                        }
                    ]
                },
                "referencesModule": {
                    "references": [
                        {
                            "pmid": "30873572",
                            "type": "BACKGROUND",
                            "citation": "Ayala F, Lopez-Valenciano A, Gamez Martin JA, De Ste Croix M, Vera-Garcia FJ, Garcia-Vaquero MDP, Ruiz-Perez I, Myer GD. A Preventive Model for Hamstring Injuries in Professional Soccer: Learning Algorithms. Int J Sports Med. 2019 May;40(5):344-353. doi: 10.1055/a-0826-1955. Epub 2019 Mar 14."
                        },
                        {
                            "pmid": "16493170",
                            "type": "BACKGROUND",
                            "citation": "Brooks JH, Fuller CW, Kemp SP, Reddin DB. Incidence, risk, and prevention of hamstring muscle injuries in professional rugby union. Am J Sports Med. 2006 Aug;34(8):1297-306. doi: 10.1177/0363546505286022. Epub 2006 Feb 21."
                        },
                        {
                            "pmid": "34794121",
                            "type": "BACKGROUND",
                            "citation": "Mendiguchia J, Castano-Zambudio A, Jimenez-Reyes P, Morin JB, Edouard P, Conceicao F, Tawiah-Dodoo J, Colyer SL. Can We Modify Maximal Speed Running Posture? Implications for Performance and Hamstring Injury Management. Int J Sports Physiol Perform. 2022 Mar 1;17(3):374-383. doi: 10.1123/ijspp.2021-0107. Epub 2021 Nov 18."
                        },
                        {
                            "pmid": "26648237",
                            "type": "BACKGROUND",
                            "citation": "Mendiguchia J, Edouard P, Samozino P, Brughelli M, Cross M, Ross A, Gill N, Morin JB. Field monitoring of sprinting power-force-velocity profile before, during and after hamstring injury: two case reports. J Sports Sci. 2016;34(6):535-41. doi: 10.1080/02640414.2015.1122207. Epub 2015 Dec 9."
                        },
                        {
                            "pmid": "28277402",
                            "type": "BACKGROUND",
                            "citation": "Mendiguchia J, Martinez-Ruiz E, Edouard P, Morin JB, Martinez-Martinez F, Idoate F, Mendez-Villanueva A. A Multifactorial, Criteria-based Progressive Algorithm for Hamstring Injury Treatment. Med Sci Sports Exerc. 2017 Jul;49(7):1482-1492. doi: 10.1249/MSS.0000000000001241."
                        },
                        {
                            "pmid": "28844725",
                            "type": "BACKGROUND",
                            "citation": "Setuain I, Lecumberri P, Izquierdo M. Sprint mechanics return to competition follow-up after hamstring injury on a professional soccer player: A case study with an inertial sensor unit based methodological approach. J Biomech. 2017 Oct 3;63:186-191. doi: 10.1016/j.jbiomech.2017.08.010. Epub 2017 Aug 20."
                        },
                        {
                            "pmid": "33362970",
                            "type": "BACKGROUND",
                            "citation": "Lahti J, Huuhka T, Romero V, Bezodis I, Morin JB, Hakkinen K. Changes in sprint performance and sagittal plane kinematics after heavy resisted sprint training in professional soccer players. PeerJ. 2020 Dec 15;8:e10507. doi: 10.7717/peerj.10507. eCollection 2020."
                        },
                        {
                            "pmid": "37712360",
                            "type": "RESULT",
                            "citation": "Sastre-Munar A, Jimenez-Reyes P, Romero-Franco N. Effects of a six-week multimodal training programme on the sprinting ability of adolescent rugby sevens players. J Sports Sci. 2023 Jun;41(10):990-998. doi: 10.1080/02640414.2023.2257514. Epub 2023 Sep 15."
                        }
                    ]
                },
                "ipdSharingStatementModule": {
                    "ipdSharing": "NO"
                }
            },
            "derivedSection": {
                "miscInfoModule": {
                    "versionHolder": "2024-11-18"
                },
                "interventionBrowseModule": {
                    "browseLeaves": [
                        {
                            "id": "M4854",
                            "name": "Benzocaine",
                            "relevance": "LOW"
                        },
                        {
                            "id": "T433",
                            "name": "Tannic Acid",
                            "relevance": "LOW"
                        }
                    ],
                    "browseBranches": [
                        {
                            "abbrev": "CNSDep",
                            "name": "Central Nervous System Depressants"
                        },
                        {
                            "abbrev": "All",
                            "name": "All Drugs and Chemicals"
                        },
                        {
                            "abbrev": "Ot",
                            "name": "Other Dietary Supplements"
                        }
                    ]
                }
            },
            "hasResults": false
        }
    ],
    "nextPageToken": "NF0g5JKAkvEgyAY"
}